
 'FISH_test_component': 'FISH test component',
 'FISH_test_component_percentage_value': 'FISH test component percentage value',
 'FISH_test_component_results': 'FISH test component results',
 'NCNNCT_OthMethONSP': 'NCNNCT_OthMethONSP',
 'acute_myeloid_leukemia_calgb_cytogenetics_risk_category': 'acute myeloid leukemia Cancer and Leukemia Group B (calgb) cytogenetics risk category',
 'additional_chemo_therapy': 'additional chemo therapy',
 'additional_drug_therapy': 'additional drug therapy',
 'additional_immuno_therapy': 'additional immuno therapy',
 'additional_pharmaceutical_therapy': 'additional pharmaceutical therapy',
 'additional_radiation_therapy': 'additional radiation therapy',
 'additional_surgery_locoregional_procedure': 'additional surgery locoregional procedure',
 'additional_surgery_metastatic_procedure': 'additional surgery metastatic procedure',
 'additional_treatment_completion_success_outcome': 'additional treatment completion success outcome',
 'additional_treatment_completion_success_outcome_type': 'additional treatment completion success outcome type',
 'additionl_mblztn_r_bltn_thrptc_prcdr_pst_rcrrnt_dss_prfrmd_ndctr': 'additional embolization or ablation therapeutic procedure post recurrent disease performed indicator',
 'addl_trtmt_success': 'additional treatmentt success',
 'adenocarcinoma_invasion': 'adenocarcinoma_invasion',
 'adjacent_hepatic_tissue_inflammation_extent_type': 'adjacent hepatic tissue inflammation extent type',
 'adjuvant_postop_targeted_therapy_admin_indicator': 'adjuvant postop targeted therapy administered indicator',
 'adjuvant_postoperative_emblztn_r_bltn_thrptc_prcdr_prfrmd_ndctr': 'adjuvant postoperative embolization or ablation therapeutic procedure performed indicator',
 'adjuvant_postoperative_embolztn_r_bltn_thrptc_prcdr_prfrmd_ndctr': 'adjuvant postoperative embolization or ablation therapeutic procedure performed indicator',
 'adjuvant_postoperative_targeted_therapy_administered_indicator': 'adjuvant postoperative targeted therapy administered indicator',
 'adjuvant_rad_therapy_prior_admin': 'adjuvant radiation therapy prior admin',
 'age_at_initial_pathologic_diagnosis': 'age at initial pathologic diagnosis',
 'age_began_smoking_in_years': 'age began smoking (years)',
 'agent_total_dose_count': 'agent total dose count',
 'ajcc_cancer_metastasis_stage_code': 'ajcc cancer metastasis stage code',
 'ajcc_cancer_staging_handbook_edition': 'american joint committee on cancer (ajcc) staging handbook edition',
 'ajcc_clinical_group_stage': 'ajcc clinical group stage',
 'ajcc_clinical_primary_tumor_m_stage': 'ajcc clinical primary tumor M stage',
 'ajcc_clinical_primary_tumor_n_stage': 'ajcc clinical primary tumor N stage',
 'ajcc_clinical_primary_tumor_t_stage': 'ajcc clinical primary tumor T stage',
 'ajcc_handbook_addition': 'american joint committee on cancer (ajcc) handbook addition',
 'ajcc_neoplasm_disease_lymph_node_stage': 'ajcc neoplasm disease lymph node stage',
 'ajcc_neoplasm_disease_stage': 'ajcc neoplasm disease stage',
 'ajcc_tumor_stage_code': 'ajcc tumor stage code',
 'alcohol_history_documented': 'alcohol history documented',
 'alcoholic_exposure_category': 'alcoholic exposure category',
 'aln_pos_ihc': 'axillary lymph nodes (aln) positive by immunohistochemistry (ihc)',
 'aln_pos_light_micro': 'axillary lymph nodes (aln) positive by light microscopy',
 'american_joint_committee_on_cancer_metastasis_stage_code': 'american joint committee on cancer metastasis stage code',
 'american_joint_committee_on_cancer_publication_version_type': 'american joint committee on cancer publication version type',
 'american_joint_committee_on_cancer_tumor_stage_code': 'american joint committee on cancer tumor stage code',
 'amount_of_alcohol_consumption_per_day': 'amount of alcohol consumption per day',
 'amt_alcohol_consumption_per_day': 'amount alcohol consumption per day',
 'anatomic_neoplasm_subdivision': 'anatomic neoplasm subdivision',
 'anatomic_neoplasm_subdivision_other': 'anatomic neoplasm subdivision other',
 'anatomic_organ_subdivision': 'anatomic organ subdivision',
 'anatomic_site_colorectal': 'anatomic site colorectal',
 'anatomic_site_location_descriptor': 'anatomic site location descriptor',
 'anatomic_site_location_descriptors': 'anatomic site location descriptors',
 'animal_insect_allergy_history': 'animal insect allergy history',
 'animal_insect_allergy_types': 'animal insect allergy types',
 'antireflux_treatment': 'anti-reflux treatment',
 'antireflux_treatment_type': 'anti-reflux treatment type',
 'antireflux_treatment_types': 'anti-reflux treatment types',
 'asthma_history': 'asthma history',
 'atra_exposure': 'atra exposure',
 'axillary_lymph_node_stage_method_type': 'axillary lymph node stage method type',
 'axillary_lymph_node_stage_other_method_descriptive_text': 'axillary lymph node stage other method descriptive text',
 'b_symptoms': 'b_symptoms',
 'barretts_esophagus': 'barretts esophagus',
 'bcr_aliquot_uuid': 'bcr aliquot uuid',
 'bcr_followup_uuid': 'BCR (Biospecimen Core Resource) followup UUID',
 'bcr_patient_uuid': 'BCR (Biospecimen Core Resource) patient UUID',
 'bcr_sample_uuid': 'BCR (Biospecimen Core Resource) sample UUID',
 'biochemical_recurrence': 'biochemical recurrence',
 'birth_control_pill_history_usage_category': 'birth control pill history usage category',
 'bladder_carcinoma_clinical_stage': 'bladder carcinoma clinical stage',
 'bladder_carcinoma_clinical_t_stage': 'bladder carcinoma clinical t stage',
 'bladder_carcinoma_extracapsular_extension_status': 'bladder carcinoma extracapsular extension status',
 'bladder_carcinoma_other_metastatic_involvement_anatomic_sit_txt': 'bladder carcinoma other metastatic involvement anatomic site',
 'bladder_carcinoma_pathologic_m_stage': 'bladder carcinoma pathologic m stage',
 'bladder_carcinoma_pathologic_n_stage': 'bladder carcinoma pathologic n stage',
 'bladder_carcinoma_pathologic_t_stage': 'bladder carcinoma pathologic t stage',
 'bladder_malignant_neoplasm_metastatic_involvement_site': 'bladder malignant neoplasm metastatic involvement site',
 'bladder_malignant_neoplasm_metastatic_involvement_sites': 'bladder malignant neoplasm metastatic involvement sites',
 'bladder_tumor_histologic_who_2004_grade': 'bladder tumor histologic WHO 2004 grade',
 'blood_relative_cancer_history_list': 'blood relative cancer history list',
 'bone_scan_results': 'bone scan results',
 'brachytherapy_administered_status': 'brachytherapy administered status',
 'brachytherapy_first_reference_point_administered_total_dose': 'brachytherapy first reference point administered total dose',
 'brachytherapy_method_other_specify_text': 'brachytherapy method other specify text',
 'brachytherapy_method_type': 'brachytherapy method type',
 'braf_gene_analysis_performed': 'BRAF gene analysis performed',
 'braf_gene_analysis_result': 'BRAF gene analysis result',
 'braf_gene_genotyping_outcome_lab_results_text': 'braf gene genotyping outcome lab results text',
 'breast_cancer_optical_measurement_histologic_type': 'breast cancer optical measurement histologic type',
 'breast_cancer_surgery_margin_status': 'breast cancer surgery margin status',
 'breast_carcinoma_estrogen_receptor_status': 'breast carcinoma estrogen receptor status',
 'breast_carcinoma_first_surgical_procedure_name': 'breast carcinoma first surgical procedure name',
 'breast_carcinoma_immunohistochemistry_er_pos_finding_scale': 'breast carcinoma immunohistochemistry ER pos finding scale',
 'breast_carcinoma_immunohistochemistry_pos_cell_score': 'breast carcinoma immunohistochemistry positive cell score',
 'breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl': 'breast carcinoma immunohistochemistry progesterone receptor pos finding scale',
 'breast_carcinoma_immunohistochemstry_prgstrn_rcptr_ps_fndng_scl': 'breast carcinoma immunohistochemstry PR pos finding scale',
 'breast_carcinoma_primary_surgical_procedure_name': 'breast carcinoma primary surgical procedure name',
 'breast_carcinoma_progesterone_receptor_status': 'breast carcinoma progesterone receptor status',
 'breast_carcinoma_surgical_procedure_name': 'breast carcinoma surgical procedure name',
 'breast_neoplasm_other_surgical_procedure_descriptive_text': 'breast neoplasm other surgical procedure descriptive text',
 'breast_tumor_clinical_m_stage': 'breast tumor clinical m stage',
 'breast_tumor_pathologic_grouping_stage': 'breast tumor pathologic grouping stage',
 'breast_tumor_pathologic_n_stage': 'breast tumor pathologic n stage',
 'breast_tumor_pathologic_t_stage': 'breast tumor pathologic t stage',
 'breslow_depth_value': 'breslow depth value',
 'cancer type': 'cancer type',
 'cancer_diagnosis_cancer_type_icd9_text_name': 'cancer diagnosis cancer type ICD-9 (International Classification of Diseases, ninth revision) code text name',
 'cancer_diagnosis_first_degree_relative_number': 'number of first degree relatives diagnosed with cancer',
 'cervical_carcinoma_clinical_stage': 'cervical carcinoma clinical stage',
 'cervical_carcinoma_corpus_uteri_involvement_indicator': 'cervical carcinoma corpus uteri involvement indicator',
 'cervical_carcinoma_pelvic_extension_text': 'cervical carcinoma pelvic extension text',
 'cervical_neoplasm_pathologic_margin_involved_text': 'cervical neoplasm pathologic margin involved text',
 'cervical_neoplasm_pathologic_margin_involved_type': 'cervical neoplasm pathologic margin involved type',
 'cervical_tumor_pathologic_n_v7_stage': 'cervical tumor pathologic n v7 stage',
 'cervical_tumor_pathologic_t_v7_stage': 'cervical tumor pathologic t v7 stage',
 'chemical_exposure_text': 'chemical exposure',
 'chemo_therapy': 'chemo therapy',
 'chemotherapy_negation_radiation_therapy_concurrent_adminstrd_txt': 'chemotherapy negation radiation therapy concurrent administered',
 'chemotherapy_negation_radiation_therapy_concurrnt_nt_dmnstrd_rsn': 'chemotherapy negation radiation therapy concurrent not administered reason',
 'chemotherapy_regimen_type': 'chemotherapy regimen type',
 'child_pugh_classification_grade': 'child pugh classification grade',
 'circumferential_resection_margin': 'circumferential resection margin',
 'city_of_procurement': 'city of procurement',
 'clinical_M': 'clinical M',
 'clinical_N': 'clinical N',
 'clinical_T': 'clinical T',
 'clinical_spread_cm': 'clinical spread cm',
 'clinical_spread_ct1': 'clinical spread ct1',
 'clinical_spread_ct2': 'clinical spread ct2',
 'clinical_spread_ct3': 'clinical spread ct3',
 'clinical_spread_ct4': 'clinical spread ct4',
 'clinical_stage': 'clinical stage',
 'colon_polyps_present': 'colon polyps present',
 'colorectal_cancer': 'colorectal cancer',
 'complete_response_observed': 'complete response observed',
 'concurrent_chemotherapy_dose': 'concurrent chemotherapy dose',
 'contiguous_organ_invaded': 'contiguous_organ_invaded',
 'contiguous_organ_resection_site': 'contiguous_organ_resection_site',
 'crvcl_tmr_pthlgc_m_stg_crvcl_cncr_pthlgc_dstnt_mtstss_tnm_fndng_': 'cervical tumor pathologic m stage cervical cancer pathologic distant metastasis tnm finding v7 stage',
 'cumulative_agent_total_dose': 'cumulative agent total dose',
 'current_weight': 'current weight',
 'cytogenetic_abnormalities': 'cytogenetic abnormalities',
 'cytogenetic_abnormality': 'cytogenetic abnormality',
 'cytogenetic_abnormality_other': 'other cytogenetic abnormality',
 'cytogenetic_analysis_performed_ind': 'cytogenetic analysis performed indicator',
 'cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr': 'cytokeratin immunohistochemistry staining method micrometastasis indicator',
 'date_of_collection': 'date of collection',
 'date_of_form_completion': 'date of form completion',
 'date_of_initial_pathologic_diagnosis': 'date of initial pathologic diagnosis',
 'date_of_sample_procurement': 'date of sample procurement',
 'date_of_tobacco_smoking_onset': 'date of tobacco smoking onset',
 'day_chemotherapy_end_number': 'end day for chemotherapy',
 'day_chemotherapy_start_number': 'start day for chemotherapy',
 'day_of_collection': 'day of collection',
 'day_of_form_completion': 'day of form completion',
 'day_of_performance_status_follow_up_score': 'day of performance status follow up score',
 'day_of_sample_procurement': 'day of sample procurement',
 'days_from_date_of_initial_pathologic_diagnosis_to_date_of_birth': 'days from date of initial pathologic diagnosis to date of birth',
 'days_to_additional_surgery_locoregional_procedure': 'days to additional surgery locoregional procedure',
 'days_to_additional_surgery_metastatic_procedure': 'days to additional surgery metastatic procedure',
 'days_to_birth': 'days to birth',
 'days_to_bone_scan_performed': 'days to bone scan performed',
 'days_to_brachytherapy_begin_occurrence': 'days to brachytherapy begin occurrence',
 'days_to_brachytherapy_end_occurrence': 'days to brachytherapy end occurrence',
 'days_to_chemotherapy_end': 'days to chemotherapy end',
 'days_to_chemotherapy_start': 'days to chemotherapy start',
 'days_to_collection': 'days to collection',
 'days_to_completion_of_curative_tx': 'days to completion of curative treatment',
 'days_to_death': 'days to death',
 'days_to_definitive_surgical_procedure_performed': 'days to definitive surgical procedure performed',
 'days_to_diabetes_onset': 'days_to_diabetes_onset',
 'days_to_diagnostic_computed_tomography_performed': 'days to diagnostic computed tomography performed',
 'days_to_diagnostic_mri_performed': 'days to diagnostic mri performed',
 'days_to_fdg_or_ct_pet_performed': 'days to FDG or CT PET performed',
 'days_to_first_biochemical_recurrence': 'days to first biochemical recurrence',
 'days_to_form_completion': 'days to form completion',
 'days_to_initial_pathologic_diagnosis': 'days to initial pathologic diagnosis',
 'days_to_initial_score_performance_status_scale': 'days to initial score performance status scale',
 'days_to_laboratory_procedure_tumor_mrkr_sqms_cll_crcnm_ntgn_rslt': 'days to laboratory procedure tumor marker squamous cell carcinoma antigen result',
 'days_to_last_followup': 'days to last followup',
 'days_to_last_known_alive': 'days to last known alive',
 'days_to_liver_graft_together_new_neoplasm_performed': 'days to liver graft together new neoplasm performed',
 'days_to_most_recent_psa': 'days to most recent PSA',
 'days_to_new_tumor_event_additional_surgery_procedure': 'days to new tumor event additional surgery procedure',
 'days_to_new_tumor_event_after_initial_treatment': 'days to new tumor event after initial treatment',
 'days_to_pancreatitis_onset': 'days to pancreatitis onset',
 'days_to_performance_status_assessment': 'days to performance status assessment',
 'days_to_performance_status_follow_up_score': 'days to performance status follow up score',
 'days_to_psa': 'days_to_psa',
 'days_to_radiation_therapy_end': 'days to radiation therapy end',
 'days_to_radiation_therapy_start': 'days to radiation therapy start',
 'days_to_sample_procurement': 'days to sample procurement',
 'days_to_second_biochemical_recurrence': 'days to second biochemical recurrence',
 'days_to_submitted_specimen_dx': 'days to submitted specimen diagnosis',
 'days_to_third_biochemical_recurrence': 'days to third biochemical recurrence',
 'days_to_tumor_progression': 'days to tumor progression',
 'days_to_tumor_recurrence': 'days to tumor recurrence',
 'days_to_well_differentiated_liposarcoma_primary_dx': 'days to well differentiated liposarcoma primary dx',
 'days_to_well_differentiated_liposarcoma_resection': 'days to well differentiated liposarcoma resection',
 'death_cause_text': 'death cause',
 'diabetes': 'diabetes',
 'diagnosis': 'diagnosis',
 'diagnosis_age': 'diagnosis age',
 'diagnosis_subtype': 'diagnosis subtype',
 'diagnostic_ct_abd_pelvis_performed': 'diagnostic ct abd pelvis performed',
 'diagnostic_ct_abd_pelvis_results': 'diagnostic ct abd pelvis results',
 'diagnostic_ct_result_outcome': 'diagnostic CT result outcome',
 'diagnostic_ct_result_outcomes': 'diagnostic CT result outcomes',
 'diagnostic_mri_performed': 'diagnostic MRI performed',
 'diagnostic_mri_result_outcome': 'diagnostic MRI result outcome',
 'diagnostic_mri_result_outcomes': 'diagnostic MRI result outcomes',
 'diagnostic_mri_results': 'diagnostic MRI results',
 'discontiguous_lesion_count': 'discontiguous_lesion_count',
 'disease_after_curative_tx': 'disease after curative treatment',
 'disease_detection_molecular_analysis_method_type': 'disease detection molecular analysis method type',
 'disease_detection_molecular_analysis_method_type_other_text': 'disease detection molecular analysis method type other text',
 'disease_extracapsular_extension_ind-3': 'disease extracapsular extension ind-3',
 'disease_extracapsular_extension_ind_3': 'disease extracapsular extension ind-3',
 'disease_surgical_margin_status': 'disease surgical margin status',
 'distant_metastasis_anatomic_site': 'distant metastasis anatomic site',
 'distant_metastasis_pathologic_spread': 'distant metastasis pathologic spread',
 'distant_metastasis_present_ind2': 'distant metastasis present ind2',
 'dlco_predictive_percent': 'dlco predictive percent',
 'dose_frequency_text': 'dose frequency (text)',
 'eastern_cancer_oncology_group': 'eastern cancer oncology group',
 'ectopic_pregnancy_count': 'ectopic pregnancy count',
 'eczema_history': 'eczema history',
 'egfr_amplication_status': 'EGFR amplication status',
 'egfr_mutation_performed': 'EGFR mutation performed',
 'egfr_mutation_result': 'EGFR mutation result',
 'eml4_alk_translocation_method': 'EML4-ALK translocation method',
 'eml4_alk_translocation_performed': 'EML4-ALK translocation performed',
 'eml4_alk_translocation_result': 'EML4-ALK translocation result',
 'endometrial_carcinoma_figo_stage': 'endometrial carcinoma federation of gynecology and obstetrics (FIGO) stage',
 'er_detection_method_text': 'ER detection method',
 'er_level_cell_percentage_category': 'estrogen receptor positive cell percentage',
 'erythrocyte_sedimentation_rate_result': 'erythrocyte sedimentation rate result',
 'external_beam_radiation_therapy_administered_status': 'external beam radiation therapy administered status',
 'external_beam_radiation_therapy_administrd_prrtc_rgn_lymph_nd_ds': 'external beam radiation therapy administered paraaortic region lymph node dose',
 'extrahepatic_recurrent_disease_anatomic_site_name': 'extrahepatic recurrent disease anatomic site name',
 'extrahepatic_recurrent_disease_location_text': 'extrahepatic recurrent disease location text',
 'extranodal_involvement': 'extranodal_involvement',
 'extrathyroid_carcinoma_present_extension_status': 'extrathyroid carcinoma present extension status',
 'family_history_of_cancer': 'family history of cancer',
 'family_history_of_primary_brain_tumor': 'family history of primary brain tumor',
 'family_history_of_stomach_cancer': 'family history of stomach cancer',
 'family_medical_history_relative_family_member_relationship_type': 'family medical history relative family member relationship type',
 'fdg_or_ct_pet_performed_outcome': 'fludeoxyglucose PET(positron emission tomography)/CT outcome',
 'fdg_or_ct_pet_performed_outcomes': 'fludeoxyglucose PET(positron emission tomography)/CT outcome',
 'female_breast_feeding_or_pregnancy_status_indicator': 'female breast feeding or pregnancy status indicator',
 'ffpe_slide_uuid': 'FFPE (formalin-fixed, paraffin-embedded) slide UUID',
 'first_degree_relative_history_thyrd_glnd_crcnm_dgnss_rltnshp_typ': 'first_degree_relative_history_thyroid_gland_carcinoma_diagnosis_relationship_type',
 'first_degree_relative_histry_thyrd_glnd_crcnm_dgnss_rltnshp_typ': 'first degree relative history thyroid gland carcinoma diagnosis relationship type',
 'first_diagnosis_age_asth_ecz_hay_fev_mold_dust': 'first diagnosis age asthma eczema hay fever mold dust',
 'first_diagnosis_age_of_animal_insect_allergy': 'first diagnosis age of animal insect allergy',
 'first_diagnosis_age_of_food_allergy': 'first diagnosis age of food allergy',
 'first_nonlymph_node_metastasis_anatomic_site': 'first nonlymph node metastasis anatomic site',
 'first_nonlymph_node_metastasis_anatomic_sites': 'first nonlymph node metastasis anatomic sites',
 'first_pathologic_diagnosis_biospecimen_acquisition_method_type': 'first pathologic diagnosis biospecimen acquisition method type',
 'first_pathologic_diagnosis_biospecimen_acquisition_othr_mthd_txt': 'other acquisition method for first pathologic diagnosis biospecimen',
 'first_presenting_symptom': 'first presenting symptom',
 'first_presenting_symptom_longest_duration': 'first presenting symptom longest duration',
 'first_recurrent_non_nodal_metastatic_anatomic_site_descriptv_txt': 'first recurrent non nodal metastatic anatomic site descriptive text',
 'first_recurrent_non_nodal_metastatic_anatomic_site_descrptv_txt': 'first recurrent non nodal metastatic anatomic site descriptive text',
 'fish_evaluation_performed_ind': 'FISH evaluation performed indicator',
 'fluorescence_in_situ_hybrid_cytogenetics_metaphas_ncls_rslt_cnt': 'fluorescence in situ hybrid cytogenetics metaphase nucleus result count',
 'fluorescence_in_situ_hybrid_cytogenetics_metaphase_ncls_rslt_cnt': 'fluorescence_in_situ_hybrid_cytogenetics_metaphase_nucleus_result_count',
 'fluorescence_in_situ_hybridization_abnormal_result_indicator': 'fluorescence in situ hybridization abnormal result indicator',
 'fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng': 'fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range',
 'fluorescence_n_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng': 'fluorescence in situ hybridization diagnostic procedure chromosome 17 signal result range',
 'followup_case_report_form_submission_reason': 'followup case report form submission reason',
 'followup_met_assessment_outcome_success_margin_status': 'followup met assessment outcome success margin status',
 'followup_treatment_success': 'followup treatment success',
 'food_allergy_history': 'food allergy history',
 'food_allergy_types': 'food allergy types',
 'freezing_method': 'freezing method',
 'frequency_of_alcohol_consumption': 'frequency of alcohol consumption',
 'gemistocytes_present': 'gemistocytes present',
 'gender': 'gender',
 'genotype_analysis_performed_indicator': 'genotype analysis performed indicator',
 'genotyping_results_gene_mutation_not_reported_reason': 'genotyping results gene mutation not reported reason',
 'gfap_positive': 'GFAP positive',
 'gleason_score': 'gleason_score',
 'gleason_score_combined_pattern_value': 'gleason score combined pattern value',
 'gynecologic_figo_staging_system': 'gynecologic federation of gynecology and obstetrics (FIGO) staging system',
 'gynecologic_tumor_grouping_figo_stage': 'gynecologic tumor grouping figo stage',
 'h_pylori_infection': 'H. Pylori infection',
 'hay_fever_history': 'hay fever history',
 'headache_history': 'headache history',
 'height': 'height',
 'hematology_serum_creatinine_laboratory_result_value_in_mg_dl': 'hematology serum creatinine laboratory result value in mg/dl',
 'hemoglobin_result': 'hemoglobin result',
 'hepatocellular_carcinoma_primary_risk_factor_name': 'hepatocellular carcinoma primary risk factor name',
 'hepatocellular_carcinoma_risk_factor_specify': 'hepatocellular carcinoma risk factor specify',
 'her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt': 'HER2 and centromere 17 positive finding other measurement scale text',
 'her2_erbb_method_calculation_method_text': 'HER2 ERBB calculation method',
 'her2_erbb_pos_finding_cell_percent_category': 'HER2 ERBB pos finding cell percent category',
 'her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt': 'HER2 ERBB pos finding fluorescence in situ hybridization calculation method',
 'her2_immunohistochemistry_level_result': 'HER2 level by immunohistochemistry',
 'her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt': 'HER2 neu and centromere 17 copy number analysis input total number count',
 'her2_neu_breast_carcinoma_copy_analysis_input_total_number': 'HER2 neu breast carcinoma copy analysis input total number',
 'her2_neu_chromosone_17_signal_ratio_value': 'HER2 neu/chromosone 17 signal ratio',
 'her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr': 'her2 neu metastatic breast carcinoma copy analysis input total number',
 'her2_neu_metastatic_breast_carcinoma_copy_analysis_npt_ttl_nmbr': 'HER2 neu metastatic breast carcinoma copy analysis input total number',
 'hist_of_non_mibc': 'hist of non mibc (non-muscle-invasive bladder cancer)',
 'histologic_classification': 'histologic classification',
 'histologic_disease_progression_present_indicator': 'histologic disease progression present indicator',
 'histologic_disease_progression_present_text': 'histologic disease progression present text',
 'histologic_disease_progression_present_type': 'histologic disease progression present type',
 'histologic_grading_tier_category': 'histologic_grading_tier_category',
 'histologic_nuclear_grade': 'histologic nuclear grade',
 'histologic_type': 'histologic type',
 'histological_subtype': 'histological subtype',
 'histological_type': 'histological type',
 'histological_type_other': 'histological type other',
 'history_of_chronic_pancreatitis': 'history of chronic pancreatitis',
 'history_of_colon_polyps': 'history of colon polyps',
 'history_of_diabetes': 'history_of_diabetes',
 'history_of_neoadjuvant_treatment': 'history of neoadjuvant treatment',
 'horm_ther': 'horm ther',
 'hormonal_therapy': 'hormonal therapy',
 'hpv_status_by_ish_testing': 'HPV status by FISH testing',
 'hpv_status_by_p16_testing': 'HPV status by p16 testing',
 'hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr': 'HER2 neu and centromere 17 copy number metastatic breast carcinoma analysis input total number count',
 'human_papillomavirus_laboratory_procedure_performed_name': 'human papillomavirus laboratory procedure performed name',
 'human_papillomavirus_laboratory_procedure_performed_text': 'human papillomavirus laboratory procedure performed text',
 'human_papillomavirus_other_type_text': 'human papillomavirus other type text',
 'human_papillomavirus_type': 'human papillomavirus type',
 'hydroxyurea_administration_prior_registration_clinicl_stdy_ndctr': 'hydroxyurea administration prior registration clinical study indicator',
 'hydroxyurea_agent_administered_day_count': 'hydroxyurea agent administered day count',
 'hypertension': 'hypertension',
 'hysterectomy_performed_text': 'hysterectomy performed text',
 'hysterectomy_performed_type': 'hysterectomy performed type',
 'i_131_first_administered_dose': 'iodide I-131 first administered dose',
 'i_131_subsequent_administered_dose': 'iodide I-131 subsequent administered dose',
 'i_131_total_administered_dose': 'iodide I-131 total administered dose',
 'i_131_total_administered_preparation_technique': 'iodide I-131 total administered preparation technique',
 'icd_10': 'International Classification of Diseases, tenth revision (ICD-10)',
 'icd_o_3_histology': 'ICD-O-3 histology',
 'icd_o_3_site': 'ICD-O-3 site',
 'immuno_therapy': 'immuno therapy',
 'immunohistochemistry_positive_cell_score': 'immunohistochemistry positive cell score',
 'immunophenotype_cytochemistry_percent_positive': 'immunophenotype cytochemistry percent positive',
 'immunophenotype_cytochemistry_testing_result': 'immunophenotype cytochemistry testing result',
 'immunophenotype_cytochemistry_testing_results': 'immunophenotype cytochemistry testing results',
 'induction_course_complete': 'induction course complete',
 'informed_consent_verified': 'informed consent verified',
 'inherited_genetic_syndrome_found': 'inherited genetic syndrome found',
 'inherited_genetic_syndrome_result': 'inherited genetic syndrome result',
 'init_pathology_dx_method_other': 'init pathology dx method other',
 'initial_pathologic_diagnosis_method': 'initial pathologic diagnosis method',
 'initial_weight': 'initial weight',
 'interferon_90_day_prior_excision_admin_indicator': 'interferon 90 day prior excision admin indicator',
 'intermediate_dimension': 'intermediate dimension',
 'karnofsky_performance_score': 'karnofsky performance score',
 'karnofsky_performance_status_score': 'karnofsky performance status score',
 'keratinizing_squamous_cell_carcinoma_present_indicator': 'keratinizing squamous cell carcinoma present indicator',
 'kras_gene_analysis_performed': 'kras gene analysis performed',
 'kras_mutation_codon': 'KRAS mutation codon',
 'kras_mutation_found': 'KRAS mutation found',
 'kras_mutation_result': 'KRAS mutation result',
 'lab_proc_her2_neu_immunohistochemistry_receptor_status': 'her2 neu immunohistochemistry receptor status',
 'lab_procedure_abnormal_lymphocyte_result_percent_value': 'abnormal lymphocyte result percentage',
 'lab_procedure_blast_cell_outcome_percentage_value': 'blast cell percentage',
 'lab_procedure_bone_marrow_band_cell_result_percent_value': 'lab procedure bone marrow band cell result percent value',
 'lab_procedure_bone_marrow_basophil_result_percent_value': 'lab procedure bone marrow basophil result percent value',
 'lab_procedure_bone_marrow_blast_cell_outcome_percent_value': 'lab procedure bone marrow blast cell outcome percent value',
 'lab_procedure_bone_marrow_cellularity_outcome_percent_value': 'lab procedure bone marrow cellularity outcome percent value',
 'lab_procedure_bone_marrow_diff_not_reported_reason': 'lab procedure bone marrow diff not reported reason',
 'lab_procedure_bone_marrow_lab_eosinophil_result_percent_value': 'lab procedure bone marrow lab eosinophil result percent value',
 'lab_procedure_bone_marrow_lymphocyte_outcome_percent_value': 'lab procedure bone marrow lymphocyte outcome percent value',
 'lab_procedure_bone_marrow_metamyelocyte_result_value': 'lab procedure bone marrow metamyelocyte result value',
 'lab_procedure_bone_marrow_myelocyte_result_percent_value': 'lab procedure bone marrow myelocyte result percent value',
 'lab_procedure_bone_marrow_neutrophil_result_percent_value': 'lab procedure bone marrow neutrophil result percent value',
 'lab_procedure_bone_marrow_prolymphocyte_result_percent_value': 'lab procedure bone marrow prolymphocyte result percent value',
 'lab_procedure_bone_marrow_promonocyte_count_result_percent_value': 'lab procedure bone marrow promonocyte count result percent value',
 'lab_procedure_bone_marrow_promyelocyte_result_percent_value': 'lab procedure bone marrow promyelocyte result percent value',
 'lab_procedure_hematocrit_outcome_percent_value': 'lab procedure hematocrit outcome percent value',
 'lab_procedure_hemoglobin_result_specified_value': 'lab procedure hemoglobin result specified value',
 'lab_procedure_her2_neu_in_situ_hybrid_outcome_type': 'lab procedure her2 neu in situ hybrid outcome type',
 'lab_procedure_leukocyte_result_unspecified_value': 'lab procedure leukocyte result unspecified value',
 'lab_procedure_monocyte_result_percent_value': 'lab procedure monocyte result percent value',
 'lab_procedure_platelet_result_specified_value': 'lab procedure platelet result specified value',
 'laboratory_prcoedure_platelet_result_lower_limit_of_normal_value': 'laboratory prcoedure platelet result lower limit of normal value',
 'laboratory_prcoedure_platelet_result_upper_limit_of_normal_value': 'laboratory prcoedure platelet result upper limit of normal value',
 'laboratory_procedure_albumin_result_lower_limit_of_normal_value': 'laboratory procedure albumin result lower limit of normal value',
 'laboratory_procedure_albumin_result_specified_value': 'laboratory procedure albumin result specified value',
 'laboratory_procedure_albumin_result_upper_limit_of_normal_value': 'laboratory procedure albumin result upper limit of normal value',
 'laboratory_procedure_alpha_fetoprotein_outcome_lwr_lmt_f_nrml_vl': 'laboratory procedure alpha fetoprotein outcome lower limit of normal value',
 'laboratory_procedure_alpha_fetoprotein_outcome_ppr_lmt_f_nrml_vl': 'laboratory procedure alpha fetoprotein outcome upper limit of normal value',
 'laboratory_procedure_alpha_fetoprotein_outcome_value': 'laboratory procedure alpha fetoprotein outcome value',
 'laboratory_procedure_creatinine_result_lower_limit_of_normal_val': 'laboratory procedure creatinine result lower limit of normal val',
 'laboratory_procedure_creatinine_result_upper_limit_of_normal_val': 'laboratory procedure creatinine result upper limit of normal val',
 'laboratory_procedure_interntnl_nrmlztn_rt_rslt_lwr_lmt_f_nrml_vl': 'laboratory procedure international normalization ratio result lower limit of normal value',
 'laboratory_procedure_interntnl_nrmlztn_rt_rslt_ppr_lmt_f_nrml_vl': 'laboratory procedure international normalization ratio result upper limit of normal value',
 'laboratory_procedure_intrntnl_nrmlztn_rt_rslt_lwr_lmt_f_nrml_vl': 'laboratory procedure international normalization ratio result lower limit of normal value',
 'laboratory_procedure_intrntnl_nrmlztn_rt_rslt_ppr_lmt_f_nrml_vl': 'laboratory procedure international normalization ratio result upper limit of normal value',
 'laboratory_procedure_platelet_result_specified_value': 'laboratory procedure platelet result specified value',
 'laboratory_procedure_prothrombin_time_result_value': 'laboratory procedure prothrombin time result value',
 'laboratory_procedure_total_bilirbn_rslt_spcfd_lwr_lmt_f_nrml_vl': 'laboratory procedure total bilirubin result specified lower limit of normal value',
 'laboratory_procedure_total_bilirbn_rslt_spcfd_ppr_lmt_f_nrml_vl': 'laboratory procedure total bilirubin result specified upper limit of normal value',
 'laboratory_procedure_total_bilirubin_result_upper_limit_norml_vl': 'laboratory procedure total bilirubin result upper limit of normal value',
 'laboratory_procedure_total_bilirubn_rslt_spcfd_lwr_lmt_f_nrml_vl': 'laboratory procedure total bilirubin result specified lower limit of normal value',
 'laboratory_procedure_total_bilirubn_rslt_spcfd_ppr_lmt_f_nrml_vl': 'laboratory procedure total bilirubin result specified upper limit of normal value',
 'laboratory_procedure_tumor_marker_squamos_cll_crcnm_ntgn_rslt_vl': 'laboratory procedure tumor marker squamous cell carcinoma antigen result value',
 'lactate_dehydrogenase_result': 'lactate dehydrogenase result',
 'laterality': 'laterality',
 'ldh1_mutation_found': 'IDH1 mutation found',
 'ldh1_mutation_test_method': 'IDH1 mutation test method',
 'ldh1_mutation_tested': 'IDH1 mutation tested',
 'leiomyosarcoma_histologic_subtype': 'leiomyosarcoma_histologic_subtype',
 'leiomyosarcoma_major_vessel_involvement': 'leiomyosarcoma_major_vessel_involvement',
 'leptomeningeal_involement': 'leptomeningeal involement',
 'leukemia_french_american_british_morphology_code': 'leukemia french american british morphology code',
 'leukemia_specimen_cell_source_type': 'leukemia specimen cell source type',
 'liver_fibrosis_ishak_score_category': 'liver fibrosis ishak score category',
 'liver_graft_together_new_neoplasm_performed_indicator': 'liver graft together new neoplasm performed indicator',
 'local_disease_recurrence': 'local_disease_recurrence',
 'location_in_lung_parenchyma': 'location in lung parenchyma',
 'longest_dimension': 'longest dimension',
 'loss_expression_of_mismatch_repair_proteins_by_ihc': 'loss expression of mismatch repair proteins by immunohistochemistry (IHC)',
 'loss_expression_of_mismatch_repair_proteins_by_ihc_result': 'loss expression of mismatch repair proteins by immunohistochemistry (IHC) result',
 'loss_expression_of_mismatch_repair_proteins_by_ihc_results': 'loss expression of mismatch repair proteins by immunohistochemistry (IHC) results',
 'lost_follow_up': 'lost follow up',
 'lymph_node_examined_count': 'lymph node examined count',
 'lymph_node_location_positive_pathology_name': 'lymph node location positive pathology name',
 'lymph_node_location_positive_pathology_text': 'lymph node location positive pathology text',
 'lymph_node_preoperative_assessment_diagnostic_imaging_type': 'lymph node preoperative assessment diagnostic imaging type',
 'lymph_node_preoperative_scan_indicator': 'lymph node preoperative scan indicator',
 'lymphatic_invasion': 'lymphatic invasion',
 'lymphatic_invasion_present': 'lymphatic invasion present',
 'lymphnode_dissection_method_left': 'lymphnode dissection method left',
 'lymphnode_dissection_method_right': 'lymphnode dissection method right',
 'lymphnode_neck_dissection': 'lymphnode neck dissection',
 'lymphnode_pathologic_spread': 'lymphnode pathologic spread',
 'lymphnodes_examined': 'lymphnodes examined',
 'lymphnodes_examined_prior_presentation': 'lymphnodes examined prior presentation',
 'lymphovascular_invasion_indicator': 'lymphovascular invasion indicator',
 'lymphovascular_invasion_present': 'lymphovascular invasion present',
 'maint_therapy_course_complete': 'maint therapy course complete',
 'malignant_neoplasm_metastatic_involvement_anatomic_site_text': 'malignant neoplasm metastatic involvement anatomic site text',
 'malignant_neoplasm_metastatic_involvement_site': 'malignant neoplasm metastatic involvement site',
 'malignant_neoplasm_mitotic_count_rate': 'malignant neoplasm mitotic count rate',
 'margin_status': 'margin status',
 'margins_involved': 'margins involved',
 'maximum_tumor_dimension': 'maximum_tumor_dimension',
 'melanoma_clark_level_value': 'melanoma clark level value',
 'melanoma_origin_skin_anatomic_site': 'melanoma origin skin anatomic site',
 'melanoma_primary_anatomic_site': 'melanoma primary anatomic site',
 'melanoma_ulceration_indicator': 'melanoma ulceration indicator',
 'menopause_status': 'menopause status',
 'mental_status_changes': 'mental status changes',
 'metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt': 'metastatic breast carcinoma positive finding progesterone receptor other measure scale text',
 'metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts': 'metastatic breast carcinoma lab procedure HER2 neu immunohistochemistry receptor status',
 'metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt': 'metastatic breast carcinoma erbb2 immunohistochemistry level result',
 'metastatic_breast_carcinoma_erbb2_immunohistochemistry_lvl_rslt': 'metastatic breast carcinoma ERBB2 immunohistochemistry level result',
 'metastatic_breast_carcinoma_estrogen_receptor_detectin_mthd_txt': 'metastatic breast carcinoma estrogen receptor detection method text',
 'metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt': 'metastatic breast carcinoma estrogen receptor detection method text',
 'metastatic_breast_carcinoma_estrogen_receptor_status': 'metastatic breast carcinoma estrogen receptor status',
 'metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry': 'metastatic breast carcinoma estrogen receptor level cell percent category',
 'metastatic_breast_carcinoma_estrogen_recptr_lvl_cll_prcnt_ctgry': 'metastatic breast carcinoma estrogen receptor level cell percent category',
 'metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt': 'metastatic breast carcinoma HER2 ERBB method calculation method text',
 'metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry': 'metastatic breast carcinoma her2 erbb pos finding cell percent category',
 'metastatic_breast_carcinoma_her2_erbb_pos_fndng_cll_prcnt_ctgry': 'metastatic breast carcinoma HER2 ERBB pos finding cell percent category',
 'metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl': 'metastatic breast carcinoma her2 neu chromosone 17 signal ratio value',
 'metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rt_vl': 'metastatic breast carcinoma HER2 neu chromosone 17 signal ratio value',
 'metastatic_breast_carcinoma_immnhstchmstry_r_pstv_fndng_scl_typ': 'metastatic breast carcinoma immunohistochemistry ER positive finding scale type',
 'metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ': 'metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type',
 'metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr': 'metastatic breast carcinoma immunohistochemistry ER positive cell score',
 'metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr': 'metastatic breast carcinoma immunohistochemistry PR positive cell score',
 'metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ': 'metastatic breast carcinoma lab proc HER2 neu in situ hybridization outcome type',
 'metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt': 'metastatic breast carcinoma pos finding her2 erbb2 other measure scale text',
 'metastatic_breast_carcinoma_pos_finding_other_scale_measrmnt_txt': 'metastatic breast carcinoma positive finding other scale measurement text',
 'metastatic_breast_carcinoma_pos_findng_hr2_rbb2_thr_msr_scl_txt': 'metastatic breast carcinoma pos finding HER2 ERBB2 other measure scale text',
 'metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry': 'metastatic breast carcinoma progesterone receptor level cell percent category',
 'metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt': 'metastatic breast carcinoma progesterone receptor detection method text',
 'metastatic_breast_carcinoma_progesterone_receptor_status': 'metastatic breast carcinoma progesterone receptor status',
 'metastatic_breast_carcinoma_progesterone_receptr_dtctn_mthd_txt': 'metastatic breast carcinoma progesterone receptor detection method text',
 'metastatic_breast_carcinoma_progestrn_rcptr_lvl_cll_prcnt_ctgry': 'metastatic breast carcinoma progesterone receptor level cell percent category',
 'metastatic_neoplasm_confirmed': 'metastatic_neoplasm_confirmed',
 'metastatic_neoplasm_confirmed_diagnosis_anatomic_site_name': 'metastatic neoplasm confirmed diagnosis anatomic site name',
 'metastatic_neoplasm_confirmed_diagnosis_method_name': 'metastatic neoplasm confirmed diagnosis method name',
 'metastatic_neoplasm_confirmed_diagnosis_method_text': 'metastatic neoplasm confirmed diagnosis method text',
 'metastatic_site_at_diagnosis': 'metastatic site at diagnosis',
 'metastatic_site_at_diagnosis_other': 'metastatic_site_at_diagnosis_other',
 'method_initial_diagnosis': 'method initial diagnosis',
 'method_of_curative_tx': 'method of curative treatment',
 'method_of_sample_procurement': 'method of sample procurement',
 'mib1_positive': 'MIB1 positive',
 'mibc_90day_post_resection_bcg': 'mibc 90day post resection bcg',
 'microsatellite_instability': 'microsatellite instability',
 'mitotic_count': 'mitotic_count',
 'mold_or_dust_allergy_history': 'mold or dust allergy history',
 'molecular_analysis_abnormal_result_indicator': 'molecular analysis abnormal result indicator',
 'molecular_analysis_abnormality_testing_percentage_value': 'molecular analysis abnormality testing percentage value',
 'molecular_analysis_abnormality_testing_result': 'molecular analysis abnormality testing result',
 'molecular_analysis_abnormality_testing_results': 'molecular analysis abnormality testing results',
 'molecular_analysis_performed_indicator': 'molecular analysis performed indicator',
 'mononucleotide_and_dinucleotide_marker_panel_analysis_status': 'microsatellite stability by mononucleotide and dinucleotide marker panel analysis',
 'mononucleotide_marker_panel_analysis_status': 'mononucleotide marker panel analysis status',
 'month_chemotherapy_end_number': 'month chemotherapy end number',
 'month_chemotherapy_start_number': 'month chemotherapy start number',
 'month_of_collection': 'month of collection',
 'month_of_form_completion': 'month of form completion',
 'month_of_performance_status_follow_up_score_event': 'month of performance status follow up score event',
 'month_of_sample_procurement': 'month of sample procurement',
 'motor_movement_changes': 'motor movement changes',
 'mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn': 'metastatic breast carcinoma fluorescence in situ hybridization diagnostic proc centromere 17 signal result range',
 'mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn_': 'metastatic breast carcinoma her2 erbb pos finding fluorescence in situ hybridization calculation method text',
 'mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ': 'metastatic breast carcinoma immunohistochemistry progesterone receptor positive finding scale type',
 'neoplasm_anatomic_subdivision': 'neoplasm anatomic subdivision',
 'neoplasm_depth': 'neoplasm depth',
 'neoplasm_disease_lymph_node_stage_american_jont_cmmtt_n_cncr_cd': 'neoplasm disease lymph node stage american joint committee on cancer code',
 'neoplasm_disease_stage_american_joint_committee_on_cancer_code': 'neoplasm disease stage american joint committee on cancer code',
 'neoplasm_excision_timepoint_pathologic_three_dimensional_siz_txt': 'neoplasm excision timepoint pathologic three dimensional size text',
 'neoplasm_histologic_grade': 'neoplasm histologic grade',
 'neoplasm_histologic_type_name': 'neoplasm histologic type name',
 'neoplasm_length': 'neoplasm length',
 'neoplasm_width': 'neoplasm width',
 'new_neoplasm_confirmed_diagnosis_method_name': 'new neoplasm confirmed diagnosis method name',
 'new_neoplasm_event_occurrence_anatomic_site': 'new neoplasm event occurrence anatomic site',
 'new_neoplasm_event_post_initial_therapy_diagnosis_method_text': 'new neoplasm event post initial therapy diagnosis method text',
 'new_neoplasm_event_post_initial_therapy_diagnosis_method_type': 'new neoplasm event post initial therapy diagnosis method type',
 'new_neoplasm_event_type': 'new neoplasm event type',
 'new_neoplasm_occurrence_anatomic_site_text': 'new neoplasm occurrence anatomic site text',
 'new_non_melanoma_event_histologic_type_text': 'new non melanoma event histologic type text',
 'new_primary_melanoma_anatomic_site': 'new primary melanoma anatomic site',
 'new_primary_melanoma_anatomic_site_other_text': 'new primary melanoma anatomic site other text',
 'new_tumor_additional_rad_tx': 'new tumor additional radiation treatment',
 'new_tumor_additional_rx_tx': 'new tumor additional drug treatment',
 'new_tumor_dx_prior_submitted_specimen_dx': 'new tumor diagnosis prior submitted specimen dx',
 'new_tumor_event_additional_surgery_procedure': 'new tumor event additional surgery procedure',
 'new_tumor_event_after_initial_treatment': 'new tumor event after initial treatment',
 'new_tumor_metastasis_anatomic_site': 'new tumor metastasis anatomic site',
 'new_tumor_metastasis_anatomic_site_other_text': 'new tumor metastasis anatomic site other text',
 'non_mibc_tx': 'non_mibc_tx',
 'non_nodal_tumor_deposits': 'non nodal tumor deposits',
 'number_of_abnormal_loci': 'number of abnormal loci',
 'number_of_first_degree_relatives_with_cancer_diagnosis': 'number of first degree relatives with cancer diagnosis',
 'number_of_loci_tested': 'number of loci tested',
 'number_of_lymphnodes_examined': 'number of lymphnodes examined',
 'number_of_lymphnodes_positive': 'number of lymphnodes positive',
 'number_of_lymphnodes_positive_by_he': 'number of lymphnodes positive by he',
 'number_of_lymphnodes_positive_by_ihc': 'number of lymphnodes positive by ihc',
 'number_of_relatives_with_stomach_cancer': 'number of relatives with stomach cancer',
 'number_of_successful_pregnancies_which_resultd_n_t_lst_1_lv_brth': 'number of successful pregnancies which resulted in at least 1 live birth',
 'number_pack_years_smoked': 'number pack years smoked',
 'number_regional_lymphnodes_exam': 'number regional lymphnodes exam',
 'number_regional_lymphnodes_pos': 'number regional lymphnodes pos',
 'occupation_primary_job': 'occupation primary job',
 'oct_embedded': 'OCT embedded (OCT is an embedding medium used for frozen tissue)',
 'oligodendroglial_component': 'oligodendroglial component',
 'oligonucleotide_primer_pair_laboratory_procedure_performed_name': 'oligonucleotide primer pair laboratory procedure performed name',
 'oligonucleotide_primer_pair_laboratory_procedure_performed_text': 'oligonucleotide primer pair laboratory procedure performed text',
 'other_chemotherapy_agent_administration_specify': 'other chemotherapy agent administration specify',
 'other_contiguous_organ_resection_site': 'other_contiguous_organ_resection_site',
 'other_genotyping_outcome_lab_results_text': 'other genotyping outcome lab results text',
 'other_histologic_subtype': 'other histologic subtype',
 'other_metastatic_involvement_anatomic_site': 'other metastatic involvement anatomic site',
 'other_method_of_sample_procurement': 'other method of sample procurement',
 'other_primary_anatomic_site': 'other primary anatomic site',
 'overall_gleason_score': 'overall gleason score',
 'p53_gene_analysis': 'TP53 gene analysis',
 'pathologic_M': 'pathologic_M',
 'pathologic_N': 'pathologic_N',
 'pathologic_T': 'pathologic_T',
 'pathologic_spread_pn': 'pathologic spread pn',
 'pathologic_spread_pt2': 'pathologic spread pt2',
 'pathologic_spread_pt2_specify': 'pathologic spread pt2 specify',
 'pathologic_spread_pt3': 'pathologic spread pt3',
 'pathologic_spread_pt3_specify': 'pathologic spread pt3 specify',
 'pathologic_spread_pt4': 'pathologic spread pt4',
 'pathologic_stage': 'pathologic_stage',
 'pathologic_tumor_burden': 'pathologic_tumor_burden',
 'pathologic_tumor_depth': 'pathologic_tumor_depth',
 'pathologic_tumor_length': 'pathologic_tumor_length',
 'pathologic_tumor_width': 'pathologic_tumor_width',
 'pathology_report_uuid': 'pathology report UUID',
 'patient_death_reason': 'patient death reason',
 'patient_history_immune_system_and_related_disorders_name': 'patient history immune system and related disorders name',
 'patient_history_immune_system_and_related_disorders_text': 'patient history immune system and related disorders text',
 'patient_id': 'patient id',
 'patient_personal_medical_history_thyroid_gland_disorder_name': 'patient personal medical history thyroid gland disorder name',
 'patient_personal_medical_history_thyroid_other_specify_text': 'patient personal medical history thyroid other specify text',
 'patient_pregnancy_spontaneous_abortion_count': 'patient pregnancy spontaneous abortion count',
 'patient_pregnancy_therapeutic_abortion_count': 'patient pregnancy therapeutic abortion count',
 'patient_smoking_history_category': 'patient smoking history category',
 'pct_tumor_invasion': 'percent tumor invasion',
 'percent_tumor_sarcomatoid': 'percent_tumor_sarcomatoid',
 'performance_status_assessment_eastern_cooperative_onclgy_grp_scl': 'performance status assessment eastern cooperative oncology group scale',
 'performance_status_assessment_timepoint_category': 'performance status assessment timepoint category',
 'performance_status_assessment_timepoint_category_other_text': 'performance status assessment timepoint category other text',
 'performance_status_scale_timing': 'performance status scale timing',
 'perineural_invasion_present': 'perineural invasion present',
 'peritoneal_wash': 'peritoneal wash',
 'person_cigarette_smoking_history_pack_year_value': 'person cigarette smoking history pack year value',
 'person_concomitant_prostate_carcinoma_occurrence_indicator': 'person concomitant prostate carcinoma occurrence indicator',
 'person_concomitant_prostate_carcinoma_pathologic_t_stage': 'person concomitant prostate carcinoma pathologic t stage',
 'person_history_leukemogenic_agent_other_exposure_text': 'person history leukemogenic agent other exposure text',
 'person_history_nonmedical_leukemia_causing_agent_type': 'person history nonmedical leukemia causing agent type',
 'person_lifetime_risk_radiation_exposure_indicator': 'person lifetime risk radiation exposure indicator',
 'person_menopause_status': 'person menopause status',
 'person_neoplasm_cancer_status': 'person neoplasm cancer status',
 'person_occupation_description_text': 'person occupation description text',
 'person_occupation_years_number': 'person occupation years number',
 'person_primary_industry_text': 'person primary industry text',
 'pgr_detection_method_text': 'PGR detection method text',
 'platelet_qualitative_result': 'platelet qualitative result',
 'pln_pos_ihc': 'positive lymph nodes (pln) by ihc',
 'pln_pos_light_micro': 'positive lymph nodes (pln) by light microscopy',
 'pos_finding_her2_erbb2_other_measurement_scale_text': 'positive finding HER2 ERBB2 other measurement scale text',
 'pos_finding_lymph_node_hematoxylin_and_eosin_stainng_mcrscpy_cnt': 'pos finding lymph node hematoxylin and eosin staining microscopy count',
 'pos_finding_lymph_node_keratin_immunohistchmstry_stnng_mthd_cnt': 'pos finding lymph node keratin immunohistochemistry staining method count',
 'pos_finding_metastatc_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt': 'pos finding metastatic breast carcinoma estrogen receptor other measuremenet scale text',
 'pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt': 'pos finding metastatic breast carcinoma estrogen receptor other measuremenet scale text',
 'pos_finding_progesterone_receptor_other_measurement_scale_text': 'pos finding progesterone receptor other measurement scale text',
 'positive_finding_estrogen_receptor_other_measurement_scale_text': 'positive finding estrogen receptor other measurement scale text',
 'positive_finding_lymph_node_hematoxylin_nd_sn_stnng_mcrscpy_cnt': 'positive finding lymph node hematoxylin and eosin staining microscopy count',
 'positive_finding_lymph_node_keratin_mmnhstchmstry_stnng_mthd_cnt': 'positive finding lymph node keratin immunohistochemistry staining method count',
 'post_bronchodilator_fev1_fvc_percent': 'post bronchodilator FEV1/FVC percent',
 'post_bronchodilator_fev1_percent': 'post bronchodilator FEV1 percent',
 'post_surgical_procedure_assessment_thyroid_gland_carcinoma_stats': 'post surgical procedure assessment thyroid gland carcinoma status',
 'post_surgical_procedure_assessment_thyroid_gland_carcinoma_stts': 'post surgical procedure assessment thyroid gland carcinoma stts',
 'postoperative_rx_tx': 'postoperative drug treatment',
 'pre_bronchodilator_fev1_fvc_percent': 'pre bronchodilator FEV1/FVC percent',
 'pre_bronchodilator_fev1_percent': 'pre bronchodilator FEV1 percent',
 'pregnancies': 'pregnancies',
 'pregnancy_stillbirth_count': 'pregnancy stillbirth count',
 'pregnant_at_diagnosis': 'pregnant_at_diagnosis',
 'preoperative_antiseizure_meds': 'preoperative antiseizure meds',
 'preoperative_corticosteroids': 'preoperative corticosteroids',
 'preoperative_pretreatment_cea_level': 'preoperative pretreatment cea level',
 'presence_of_pathological_nodal_extracapsular_spread': 'presence of pathological nodal extracapsular spread',
 'presence_of_sarcomatoid_features': 'presence_of_sarcomatoid_features',
 'pretreatment_history': 'pretreatment history',
 'primary_anatomic_site_count': 'primary anatomic site count',
 'primary_gleason_grade': 'primary gleason grade',
 'primary_lymph_node_presentation_assessment': 'primary lymph node presentation assessment',
 'primary_lymph_node_presentation_assessment_ind': 'primary lymph node presentation assessment indicator',
 'primary_melanoma_at_diagnosis_count': 'primary melanoma at diagnosis count',
 'primary_neoplasm_focus_type': 'primary neoplasm focus type',
 'primary_neoplasm_melanoma_dx': 'primary neoplasm melanoma diagnosis',
 'primary_or_metastatic_status': 'primary or metastatic status',
 'primary_ormetastatic_status': 'primary ormetastatic status',
 'primary_other_site_of_disease_name': 'primary other site of disease name',
 'primary_pattern': 'primary_pattern',
 'primary_therapy_outcome_success': 'primary therapy outcome success',
 'primary_therapy_outcome_success_type': 'primary therapy outcome success type',
 'primary_thyroid_gland_neoplasm_location_anatomic_site': 'primary thyroid gland neoplasm location anatomic site',
 'primary_tumor_lower_uterus_segment': 'primary_tumor_lower_uterus_segment',
 'primary_tumor_multiple_present_ind': 'primary tumor multiple present indicator',
 'primary_tumor_pathologic_spread': 'primary tumor pathologic spread',
 'prior_diagnosis': 'prior diagnosis',
 'prior_dx': 'prior diagnosis',
 'prior_glioma': 'prior glioma',
 'prior_hematologic_disorder_diagnosis_indicator': 'prior hematologic disorder diagnosis indicator',
 'prior_radiation_therapy': 'prior radiation therapy',
 'prior_systemic_therapy_type': 'prior systemic therapy type',
 'prior_tamoxifen_administered_usage_category': 'prior tamoxifen administered usage category',
 'progesterone_receptor_level_cell_percent_category': 'progesterone receptor level cell percent category',
 'progression_determined_by': 'progression determined by',
 'progression_determined_by_notes': 'progression determined by notes',
 'prosp_tissue_coll': 'prospect tissue collection',
 'psa_result_most_recent': 'PSA result most recent',
 'psa_value': 'psa_value',
 'pulmonary_function_test_performed': 'pulmonary function test performed',
 'rad_tx_primary_neoplasm_admin': 'radiation treatment primary neoplasm admin',
 'radiation_supplemental': 'radiation supplemental',
 'radiation_therapy': 'radiation therapy',
 'radiation_therapy_administered_dose_text': 'radiation therapy administered dose text',
 'radiation_therapy_administered_preparation_technique_text': 'radiation therapy administered preparation technique text',
 'radiation_therapy_not_administered_reason': 'radiation therapy not administered reason',
 'radiation_therapy_not_administered_specify': 'radiation therapy not administered specify',
 'radiation_type_notes': 'radiation type notes',
 'radiologic_tumor_burden': 'radiologic_tumor_burden',
 'radiologic_tumor_depth': 'radiologic_tumor_depth',
 'radiologic_tumor_length': 'radiologic_tumor_length',
 'radiologic_tumor_width': 'radiologic_tumor_width',
 'radiosensitizing_agent_administered_indicator': 'radiosensitizing agent administered indicator',
 'ras_family_gene_genotyping_outcome_lab_results_text': 'RAS family gene genotyping outcome lab results text',
 'recurrence_second_surgery_neoplasm_surgical_procedure_name': 'recurrence second surgery neoplasm surgical procedure name',
 'recurrence_second_surgery_neoplasm_surgical_procedure_name_other': 'recurrence second surgery neoplasm surgical procedure name other',
 'reflux_history': 'reflux history',
 'relative_cancer_type': 'relative_cancer_type',
 'relative_family_cancer_history_ind_3': 'family cancer history ind 3',
 'residual_disease_post_new_tumor_event_margin_status': 'residual disease post new tumor event margin status',
 'residual_tumor': 'residual tumor',
 'resp_maint_from_bcg_admin_month_dur': 'resp_maint_from_bcg_admin_month_dur',
 'ret_ptc_rearrangement_genotyping_outcome_lab_results_text': 'RET/PTC rearrangement genotyping results',
 'retro_tissue_coll': 'retrospect tissue collection',
 'rt_administered_type': 'radiation administered type',
 'rt_pelvis_administered_total_dose': 'radiation pelvis administered total dose',
 'sample_type': 'sample type',
 'sample_type_id': 'sample type id',
 'secondary_gleason_grade': 'secondary gleason grade',
 'secondary_pattern': 'secondary_pattern',
 'seizure_history': 'seizure history',
 'sensory_changes': 'sensory changes',
 'serum_calcium_result': 'serum calcium result',
 'shortest_dimension': 'shortest dimension',
 'site_of_additional_surgery_new_tumor_event_mets': 'site of additional surgery new tumor event mets',
 'site_of_tumor_first_recurrence': 'site of tumor first recurrence',
 'smokeless_tobacco_use_age_at_quit': 'age quit smokeless tobacco use',
 'smokeless_tobacco_use_age_at_start': 'age start smokeless tobacco use',
 'smokeless_tobacco_use_at_diag': 'smokeless tobacco use at diagnosis',
 'smokeless_tobacco_use_per_day': 'smokeless tobacco use per day',
 'smokeless_tobacco_use_regularly': 'smokeless tobacco use regularly',
 'source_of_patient_death_reason': 'source of patient death reason',
 'specific_tumor_total_necrosis_percent': 'specific tumor total necrosis percent',
 'specimen_collection_method_name': 'specimen collection method name',
 'specimen_histologic_type_type_histologictype': 'specimen histologic type type histologictype',
 'standardized_uptake_value_cervix_uteri_assessment_measurement': 'standardized uptake value cervix uteri assessment measurement',
 'state_province_country_of_procurement': 'state province country of procurement',
 'steroid_therapy_administered': 'steroid therapy administered',
 'stomach_neoplasm_anatomic_subsite': 'stomach neoplasm anatomic subsite',
 'stopped_smoking_year': 'stopped smoking year',
 'subsequent_primary_melanoma_during_followup': 'subsequent primary melanoma during followup',
 'supratentorial_localization': 'supratentorial localization',
 'surgery_performed_type': 'surgery performed',
 'surgery_performed_type_other': 'surgery performed type other',
 'surgical_approach': 'surgical approach',
 'surgical_margin_resection_status': 'surgical margin resection status',
 'surgical_procedure_name_other_specify_text': 'surgical procedure name other specify text',
 'surgical_procedure_purpose_other_text': 'surgical procedure purpose other text',
 'synchronous_colon_cancer_present': 'synchronous colon cancer present',
 'system_version': 'system_version',
 'targeted_molecular_therapy': 'targeted molecular therapy',
 'tcgaBarCode': 'tcgaBarCode',
 'tertiary_gleason_pattern': 'tertiary gleason pattern',
 'tertiary_pattern': 'tertiary pattern',
 'therapeutic_ionizing_head_radiation': 'therapeutic ionizing head radiation',
 'therapeutic_procedure_new_neoplasm_required_additional_thrpy_typ': 'therapeutic_procedure_new_neoplasm_required_additional_therapy_type',
 'therapeutic_procedure_new_neoplasm_required_additionl_thrpy_typ': 'therapeutic procedure new neoplasm required additional thrapy type',
 'thyroid_gland_carcinoma_involvement_regional_lymph_node_type': 'thyroid gland carcinoma involvement regional lymph node type',
 'thyroid_gland_carcinoma_regional_lymph_nod_nvlvmnt_ntmc_sts_txt': 'thyroid gland carcinoma regional lymph node involvement anatomic sites',
 'thyroid_gland_carcinoma_regional_lymph_node_nvlvmnt_ntmc_sts_txt': 'thyroid gland carcinoma regional lymph node involvement anatomic sites',
 'time_between_clamping_and_freezing': 'time between clamping and freezing',
 'time_between_excision_and_freezing': 'time between excision and freezing',
 'tissue_prospective_collection_indicator': 'tissue prospective collection indicator',
 'tissue_retrospective_collection_indicator': 'tissue retrospective collection indicator',
 'tissue_source_site': 'tissue source site',
 'tnm_pathology_lymphnode_status': 'TNM (tumor, node, metastasis) pathology lymphnode status',
 'tnm_pathology_metastatic_status': 'TNM (tumor, node, metastasis) pathology metastatic status',
 'tnm_pathology_stage_grouping': 'TNM (tumor, node, metastasis) pathology stage grouping',
 'tnm_pathology_tumor_status': 'TNM (tumor, node, metastasis) pathology tumor status',
 'tobacco_smoking_history': 'tobacco_smoking_history',
 'tobacco_smoking_history_indicator': 'tobacco smoking history indicator',
 'total_aor-lnp': 'total aor lymph node positive',
 'total_aor_lnp': 'total aor lymph node positive',
 'total_aor_lnr': 'total aor lymph node ratio',
 'total_dose_units': 'total dose units',
 'total_number_of_pregnancies': 'total number of pregnancies',
 'total_pelv_lnp': 'total pelv lymph node positive',
 'total_pelv_lnr': 'total pelv lymph node ratio',
 'tumor_anatomic_site': 'tumor anatomic site',
 'tumor_depth': 'tumor depth',
 'tumor_disease_anatomic_site': 'tumor disease anatomic site',
 'tumor_grade': 'tumor grade',
 'tumor_histologic_subtype': 'tumor histologic subtype',
 'tumor_histologic_subtype_type': 'tumor histologic subtype',
 'tumor_level': 'tumor level',
 'tumor_location': 'tumor location',
 'tumor_lymphovascular_invasion_ind': 'tumor lymphovascular invasion indicator',
 'tumor_multifocal': 'tumor multifocal',
 'tumor_necrosis_percent': 'tumor necrosis percent',
 'tumor_nuclei_percent': 'tumor nuclei percent',
 'tumor_other_histologic_subtype_descriptive_text': 'tumor other histologic subtype descriptive text',
 'tumor_pathology': 'tumor pathology',
 'tumor_residual_disease': 'tumor residual disease',
 'tumor_response_cdus_type': 'tumor response CDUS (colour doppler ultrasound) type',
 'tumor_sample_anatomic_location': 'tumor sample anatomic location',
 'tumor_stage': 'tumor stage',
 'tumor_tissue_site': 'tumor tissue site',
 'tumor_tissue_site_other': 'tumor_tissue_site_other',
 'tumor_total_necrosis_percent': 'tumor total necrosis percent',
 'tumor_type': 'tumor type',
 'tumor_weight': 'tumor weight',
 'type_ofprogression_of_disease_ht': 'type of progression of disease ht',
 'vascular_invasion_present': 'vascular invasion present',
 'vascular_tumor_cell_invasion_type': 'vascular tumor cell invasion type',
 'venous_invasion': 'venous invasion',
 'verification_by_bcr': 'verification by BCR (Biospecimen Core Resource)',
 'vial_number': 'vial number',
 'visual_changes': 'visual changes',
 'vital_status': 'vital status',
 'weight': 'weight',
 'well_differentiated_liposarcoma_primary_dx': 'well differentiated liposarcoma primary dx',
 'white_cell_count_result': 'white cell count result',
 'year_chemotherapy_end_number': 'year chemotherapy end number',
 'year_chemotherapy_start_number': 'year chemotherapy start number',
 'year_of_collection': 'year of collection',
 'year_of_form_completion': 'year of form completion',
 'year_of_initial_pathologic_diagnosis': 'year of initial pathologic diagnosis',
 'year_of_performance_status_follow_up_score': 'year of performance status follow up score',
 'year_of_sample_procurement': 'year of sample procurement',
 'year_of_tobacco_smoking_cessation': 'year of tobacco smoking cessation',
 'year_of_tobacco_smoking_onset': 'year of tobacco smoking onset',
 'zone_of_origin': 'zone of origin',
 'percent_lymphocyte_infiltration_BOTTOM':'percent_lymphocyte_infiltration BOTTOM of slide',
 'percent_lymphocyte_infiltration_TOP':'percent_lymphocyte_infiltration TOP of slide',
 'percent_monocyte_infiltration_BOTTOM':'percent_monocyte_infiltration BOTTOM of slide',
 'percent_monocyte_infiltration_TOP':'percent_monocyte_infiltration TOP of slide',
 'percent_necrosis_BOTTOM':'percent_necrosis BOTTOM of slide',
 'percent_necrosis_TOP':'percent_necrosis TOP of slide',
 'percent_neutrophil_infiltration_BOTTOM':'percent_neutrophil_infiltration BOTTOM of slide',
 'percent_neutrophil_infiltration_TOP':'percent_neutrophil_infiltration TOP of slide',
 'percent_normal_cells_BOTTOM':'percent_normal_cells BOTTOM of slide',
 'percent_normal_cells_TOP':'percent_normal_cells TOP of slide',
 'percent_stromal_cells_BOTTOM':'percent_stromal_cells BOTTOM of slide',
 'percent_stromal_cells_TOP':'percent_stromal_cells TOP of slide',
 'percent_tumor_cells_BOTTOM':'percent_tumor_cells BOTTOM of slide',
 'percent_tumor_cells_TOP':'percent_tumor_cells TOP of slide',
 'percent_tumor_nuclei_BOTTOM':'percent_tumor_nuclei BOTTOM of slide',
 'percent_tumor_nuclei_TOP':'percent_tumor_nuclei TOP of slide',
}

featureShortTitle= {'': '',
 'FISH_test_component': 'FISH test component',
 'FISH_test_component_percentage_value': 'FISH test component pct',
 'FISH_test_component_results': 'FISH test component results',
 'NCNNCT_OthMethONSP': 'NCNNCT_OthMethONSP',
 'acute_myeloid_leukemia_calgb_cytogenetics_risk_category': 'AML calgb cytogenetics risk category',
 'additional_chemo_therapy': 'addtl chemo Tx',
 'additional_drug_therapy': 'addtl drug Tx',
 'additional_immuno_therapy': 'addtl immuno Tx',
 'additional_pharmaceutical_therapy': 'addtl pharm Tx',
 'additional_radiation_therapy': 'addtl rad Tx',
 'additional_surgery_locoregional_procedure': 'addtl surgery locoregional proc',
 'additional_surgery_metastatic_procedure': 'addtl surgery metastatic proc',
 'additional_treatment_completion_success_outcome': 'addtl Tx completion success outcome',
 'additional_treatment_completion_success_outcome_type': 'addtl Tx completion success outcome type',
 'additionl_mblztn_r_bltn_thrptc_prcdr_pst_rcrrnt_dss_prfrmd_ndctr': 'addtl ablation Tx post recur disease performed',
 'addl_trtmt_success': 'addtl Tx success',
 'adenocarcinoma_invasion': 'adenocarcinoma_invasion',
 'adjacent_hepatic_tissue_inflammation_extent_type': 'adjacent hepatic tissue inflammation extent type',
 'adjuvant_postop_targeted_therapy_admin_indicator': 'adj postop targeted therapy administered',
 'adjuvant_postoperative_emblztn_r_bltn_thrptc_prcdr_prfrmd_ndctr': 'adj postop ablation Tx performed',
 'adjuvant_postoperative_embolztn_r_bltn_thrptc_prcdr_prfrmd_ndctr': 'adjuvant_postoperative_embolization_or_ablation_therapeutic_procedure_performed_indicator',
 'adjuvant_postoperative_targeted_therapy_administered_indicator': 'adj postop targeted Tx administered',
 'adjuvant_rad_therapy_prior_admin': 'adj rad Tx prior admin',
 'age_at_initial_pathologic_diagnosis': 'age Dx',
 'age_began_smoking_in_years': 'age began smoking',
 'agent_total_dose_count': 'agent total dose count',
 'ajcc_cancer_metastasis_stage_code': 'AJCC cancer metastasis stage',
 'ajcc_cancer_staging_handbook_edition': 'AJCC staging handbook edition',
 'ajcc_clinical_group_stage': 'ajcc clinical group stage',
 'ajcc_clinical_primary_tumor_m_stage': 'ajcc clinical primary tumor M stage',
 'ajcc_clinical_primary_tumor_n_stage': 'ajcc clinical primary tumor N stage',
 'ajcc_clinical_primary_tumor_t_stage': 'ajcc clinical primary tumor T stage',
 'ajcc_handbook_addition': 'AJCC handbook addition',
 'ajcc_neoplasm_disease_lymph_node_stage': 'AJCC neoplasm disease LN stage',
 'ajcc_neoplasm_disease_stage': 'AJCC neoplasm disease stage',
 'ajcc_tumor_stage_code': 'AJCC tumor stage',
 'alcohol_history_documented': 'alcohol history documented',
 'alcoholic_exposure_category': 'alcoholic_exposure_category',
 'aln_pos_ihc': 'aln+ by ihc',
 'aln_pos_light_micro': 'aln+ by microscopy',
 'american_joint_committee_on_cancer_metastasis_stage_code': 'AJCC metastasis stage code',
 'american_joint_committee_on_cancer_publication_version_type': 'AJCC cancer publication version type',
 'american_joint_committee_on_cancer_tumor_stage_code': 'AJCC tumor stage code',
 'amount_of_alcohol_consumption_per_day': 'alcohol consumption /day',
 'amt_alcohol_consumption_per_day': 'amt_alcohol_consumption_per_day',
 'anatomic_neoplasm_subdivision': 'anatomic_neoplasm_subdivision',
 'anatomic_neoplasm_subdivision_other': 'anatomic_neoplasm_subdivision_other',
 'anatomic_organ_subdivision': 'anatomic organ subdivision',
 'anatomic_site_colorectal': 'anatomic site colorectal',
 'anatomic_site_location_descriptor': 'anatomic site location',
 'anatomic_site_location_descriptors': 'anatomic site location',
 'animal_insect_allergy_history': 'allergy history',
 'animal_insect_allergy_types': 'allergy types',
 'antireflux_treatment': 'anti-reflux Tx',
 'antireflux_treatment_type': 'anti-reflux Tx type',
 'antireflux_treatment_types': 'anti-reflux Tx types',
 'asthma_history': 'asthma history',
 'atra_exposure': 'atra exposure',
 'axillary_lymph_node_stage_method_type': 'ALN stage method',
 'axillary_lymph_node_stage_other_method_descriptive_text': 'ALN stage other method',
 'b_symptoms': 'b_symptoms',
 'barretts_esophagus': 'barretts esophagus',
 'bcr_aliquot_uuid': 'bcr aliquot uuid',
 'bcr_followup_uuid': 'BCR followup uuid',
 'bcr_patient_uuid': 'BCR patient uuid',
 'bcr_sample_uuid': 'BCR sample uuid',
 'biochemical_recurrence': 'biochem recur',
 'birth_control_pill_history_usage_category': 'birth control pill usage',
 'bladder_carcinoma_clinical_stage': 'BLCA clin stage',
 'bladder_carcinoma_clinical_t_stage': 'BLCA clin t stage',
 'bladder_carcinoma_extracapsular_extension_status': 'BLCA extracapsular ext stat',
 'bladder_carcinoma_other_metastatic_involvement_anatomic_sit_txt': 'BLCA other mets site',
 'bladder_carcinoma_pathologic_m_stage': 'BLCA path m stage',
 'bladder_carcinoma_pathologic_n_stage': 'BLCA path n stage',
 'bladder_carcinoma_pathologic_t_stage': 'BLCA path t stage',
 'bladder_malignant_neoplasm_metastatic_involvement_site': 'bladder malignant neoplasm mets site',
 'bladder_malignant_neoplasm_metastatic_involvement_sites': 'bladder malignant neoplasm mets site',
 'bladder_tumor_histologic_who_2004_grade': 'bladder tumor hist WH02004 grade',
 'blood_relative_cancer_history_list': 'blood relative cancer history',
 'bone_scan_results': 'bone scan results',
 'brachytherapy_administered_status': 'brachytherapy admin stat',
 'brachytherapy_first_reference_point_administered_total_dose': 'brachytherapy 1st ref admin total dose',
 'brachytherapy_method_other_specify_text': 'brachytherapy other text',
 'brachytherapy_method_type': 'brachytherapy method type',
 'braf_gene_analysis_performed': 'BRAF gene analysis performed',
 'braf_gene_analysis_result': 'BRAF mutation',
 'braf_gene_genotyping_outcome_lab_results_text': 'BRAF genotyping outcome lab result',
 'breast_cancer_optical_measurement_histologic_type': 'BRCA optical measurement hist type',
 'breast_cancer_surgery_margin_status': 'BRCA surgery margin stat',
 'breast_carcinoma_estrogen_receptor_status': 'ER status',
 'breast_carcinoma_first_surgical_procedure_name': 'BRCA first surgical proc',
 'breast_carcinoma_immunohistochemistry_er_pos_finding_scale': 'BRCA IHC ER pos scale',
 'breast_carcinoma_immunohistochemistry_pos_cell_score': 'BRCA IHC+ cell score',
 'breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl': 'breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale',
 'breast_carcinoma_immunohistochemstry_prgstrn_rcptr_ps_fndng_scl': 'BRCA IHC PR pos scale',
 'breast_carcinoma_primary_surgical_procedure_name': 'BRCA primary surgical proc',
 'breast_carcinoma_progesterone_receptor_status': 'PR status',
 'breast_carcinoma_surgical_procedure_name': 'BRCA surgical proc',
 'breast_neoplasm_other_surgical_procedure_descriptive_text': 'breast neoplasm other surgical proc',
 'breast_tumor_clinical_m_stage': 'breast tumor clin m stage',
 'breast_tumor_pathologic_grouping_stage': 'breast tumor path grouping stage',
 'breast_tumor_pathologic_n_stage': 'breast tumor path n stage',
 'breast_tumor_pathologic_t_stage': 'breast tumor path t stage',
 'breslow_depth_value': 'breslow depth',
 'cancer type': 'cancer type',
 'cancer_diagnosis_cancer_type_icd9_text_name': 'ICD-9 code',
 'cancer_diagnosis_first_degree_relative_number': 'no. 1st degree relatives Dx cancer',
 'cervical_carcinoma_clinical_stage': 'CESC clin stage',
 'cervical_carcinoma_corpus_uteri_involvement_indicator': 'CESC corpus uteri involv',
 'cervical_carcinoma_pelvic_extension_text': 'CESC pelvic ext',
 'cervical_neoplasm_pathologic_margin_involved_text': 'cervical neoplasm path margin text',
 'cervical_neoplasm_pathologic_margin_involved_type': 'cervical neoplasm path margin type',
 'cervical_tumor_pathologic_n_v7_stage': 'cervical tumor path n v7 stage',
 'cervical_tumor_pathologic_t_v7_stage': 'cervical tumor path t v7 stage',
 'chemical_exposure_text': 'chemical exposure',
 'chemo_therapy': 'chemo Tx',
 'chemotherapy_negation_radiation_therapy_concurrent_adminstrd_txt': 'chemo negation rad Tx concur admin',
 'chemotherapy_negation_radiation_therapy_concurrnt_nt_dmnstrd_rsn': 'chemo negation rad Tx concur not admin reason',
 'chemotherapy_regimen_type': 'chemo type',
 'child_pugh_classification_grade': 'child pugh classif grade',
 'circumferential_resection_margin': 'circumferential resection margin',
 'city_of_procurement': 'city of procurement',
 'clinical_M': 'clinical_M',
 'clinical_N': 'clinical_N',
 'clinical_T': 'clinical_T',
 'clinical_spread_cm': 'clinical spread cm',
 'clinical_spread_ct1': 'clinical spread ct1',
 'clinical_spread_ct2': 'clinical spread ct2',
 'clinical_spread_ct3': 'clinical spread ct3',
 'clinical_spread_ct4': 'clinical spread ct4',
 'clinical_stage': 'clinical_stage',
 'colon_polyps_present': 'colon polyps present',
 'colorectal_cancer': 'colorectal cancer',
 'complete_response_observed': 'complete response observed',
 'concurrent_chemotherapy_dose': 'concurrent chemo dose',
 'contiguous_organ_invaded': 'contiguous_organ_invaded',
 'contiguous_organ_resection_site': 'contiguous_organ_resection_site',
 'crvcl_tmr_pthlgc_m_stg_crvcl_cncr_pthlgc_dstnt_mtstss_tnm_fndng_': 'cervical tumor path m stage cervical cancer pathologic distant metastasis tnm finding v7 stage',
 'cumulative_agent_total_dose': 'cumulative agent total dose',
 'current_weight': 'current weight',
 'cytogenetic_abnormalities': 'cytogenetic abnormalities',
 'cytogenetic_abnormality': 'cytogenetic abnormality',
 'cytogenetic_abnormality_other': 'other cytogenetic abnormality',
 'cytogenetic_analysis_performed_ind': 'cytogenetic analysis performed',
 'cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr': 'cytokeratin IHC method micrometastasis indicator',
 'date_of_collection': 'date of collection',
 'date_of_form_completion': 'date of form completion',
 'date_of_initial_pathologic_diagnosis': 'date of initial pathologic diagnosis',
 'date_of_sample_procurement': 'date of sample procurement',
 'date_of_tobacco_smoking_onset': 'date of tobacco smoking onset',
 'day_chemotherapy_end_number': 'end day chemo',
 'day_chemotherapy_start_number': 'start day chemo',
 'day_of_collection': 'day of collection',
 'day_of_form_completion': 'day of form completion',
 'day_of_performance_status_follow_up_score': 'day of performance stat followup score',
 'day_of_sample_procurement': 'day of sample procurement',
 'days_from_date_of_initial_pathologic_diagnosis_to_date_of_birth': 'days_from_date_of_initial_pathologic_diagnosis_to_date_of_birth',
 'days_to_additional_surgery_locoregional_procedure': 'days to addtl surgery locoregional proc',
 'days_to_additional_surgery_metastatic_procedure': 'days to addtl surgery metastatic proc',
 'days_to_birth': 'days to birth',
 'days_to_bone_scan_performed': 'days to bone scan',
 'days_to_brachytherapy_begin_occurrence': 'days to brachytherapy begin',
 'days_to_brachytherapy_end_occurrence': 'days to brachytherapy end',
 'days_to_chemotherapy_end': 'days to chemo end',
 'days_to_chemotherapy_start': 'days to chemo start',
 'days_to_collection': 'days to collection',
 'days_to_completion_of_curative_tx': 'days to completion of curative tx',
 'days_to_death': 'days to death',
 'days_to_definitive_surgical_procedure_performed': 'days to definitive surgical proc',
 'days_to_diabetes_onset': 'days_to_diabetes_onset',
 'days_to_diagnostic_computed_tomography_performed': 'days to Dx CT',
 'days_to_diagnostic_mri_performed': 'days to Dx MRI',
 'days_to_fdg_or_ct_pet_performed': 'days to FDG or CT PET',
 'days_to_first_biochemical_recurrence': 'days to 1st biochem recur',
 'days_to_form_completion': 'days to form completion',
 'days_to_initial_pathologic_diagnosis': 'days to initial path Dx',
 'days_to_initial_score_performance_status_scale': 'days to initial score performance status scale',
 'days_to_laboratory_procedure_tumor_mrkr_sqms_cll_crcnm_ntgn_rslt': 'days to lab proc tumor marker squamous cell carcinoma antigen result',
 'days_to_last_followup': 'days to last followup',
 'days_to_last_known_alive': 'days to last known alive',
 'days_to_liver_graft_together_new_neoplasm_performed': 'days to liver graft new neoplasm performed',
 'days_to_most_recent_psa': 'days to most recent PSA',
 'days_to_new_tumor_event_additional_surgery_procedure': 'days to new tumor addtl surgery',
 'days_to_new_tumor_event_after_initial_treatment': 'days to new tumor after initial Tx',
 'days_to_pancreatitis_onset': 'days_to_pancreatitis_onset',
 'days_to_performance_status_assessment': 'days to performance stat assess',
 'days_to_performance_status_follow_up_score': 'days to performance stat followup score',
 'days_to_psa': 'days_to_psa',
 'days_to_radiation_therapy_end': 'days to rad Tx end',
 'days_to_radiation_therapy_start': 'days to rad Tx start',
 'days_to_sample_procurement': 'days to sample procurement',
 'days_to_second_biochemical_recurrence': 'days to 2nd biochem recur',
 'days_to_submitted_specimen_dx': 'days to specimen Dx',
 'days_to_third_biochemical_recurrence': 'days to 3rd biochem recur',
 'days_to_tumor_progression': 'days to tumor progression',
 'days_to_tumor_recurrence': 'days to tumor recurrence',
 'days_to_well_differentiated_liposarcoma_primary_dx': 'days_to_well_differentiated_liposarcoma_primary_dx',
 'days_to_well_differentiated_liposarcoma_resection': 'days_to_well_differentiated_liposarcoma_resection',
 'death_cause_text': 'death cause',
 'diabetes': 'diabetes',
 'diagnosis': 'diagnosis',
 'diagnosis_age': 'diagnosis age',
 'diagnosis_subtype': 'diagnosis subtype',
 'diagnostic_ct_abd_pelvis_performed': 'Dx CT abd pelvis performed',
 'diagnostic_ct_abd_pelvis_results': 'Dx CT abd pelvis',
 'diagnostic_ct_result_outcome': 'Dx CT result',
 'diagnostic_ct_result_outcomes': 'Dx CT result',
 'diagnostic_mri_performed': 'Dx MRI performed',
 'diagnostic_mri_result_outcome': 'Dx MRI result',
 'diagnostic_mri_result_outcomes': 'Dx MRI result',
 'diagnostic_mri_results': 'Dx MRI results',
 'discontiguous_lesion_count': 'discontiguous_lesion_count',
 'disease_after_curative_tx': 'disease after curative tx',
 'disease_detection_molecular_analysis_method_type': 'disease detection molecular analysis method',
 'disease_detection_molecular_analysis_method_type_other_text': 'disease detection molecular analysis method other text',
 'disease_extracapsular_extension_ind-3': 'disease extracapsular extension ind3',
 'disease_extracapsular_extension_ind_3': 'disease extracapsular extension ind3',
 'disease_surgical_margin_status': 'disease surgical margin stat',
 'distant_metastasis_anatomic_site': 'distant metastasis site',
 'distant_metastasis_pathologic_spread': 'M (TNM)',
 'distant_metastasis_present_ind2': 'distant metastasis present',
 'dlco_predictive_percent': 'DLCO pred pct',
 'dose_frequency_text': 'dose frequency',
 'eastern_cancer_oncology_group': 'eastern cancer oncology group',
 'ectopic_pregnancy_count': 'ectopic pregnancy count',
 'eczema_history': 'eczema history',
 'egfr_amplication_status': 'EGFR amplication stat',
 'egfr_mutation_performed': 'EGFR mutation performed',
 'egfr_mutation_result': 'EGFR mutation result',
 'eml4_alk_translocation_method': 'EML4-ALK translocation method',
 'eml4_alk_translocation_performed': 'EML4-ALK translocation performed',
 'eml4_alk_translocation_result': 'EML4-ALK translocation result',
 'endometrial_carcinoma_figo_stage': 'UCEC FIGO stage',
 'er_detection_method_text': 'ER detect method',
 'er_level_cell_percentage_category': 'ER',
 'erythrocyte_sedimentation_rate_result': 'ESR',
 'external_beam_radiation_therapy_administered_status': 'external beam rad Tx admin status',
 'external_beam_radiation_therapy_administrd_prrtc_rgn_lymph_nd_ds': 'external beam rad Tx admin paraaortic region LN dose',
 'extrahepatic_recurrent_disease_anatomic_site_ame': 'extrahepatic recur disease site',
 'extrahepatic_recurrent_disease_location_text': 'extrahepatic recur disease loc',
 'extranodal_involvement': 'extranodal_involvement',
 'family_history_of_cancer': 'family history of cancer',
 'family_history_of_primary_brain_tumor': 'family history of primary brain tumor',
 'family_history_of_stomach_cancer': 'family history of stomach cancer',
 'family_medical_history_relative_family_member_relationship_type': 'family member relationship',
 'fdg_or_ct_pet_performed_outcome': 'FDG PET/CT outcome',
 'fdg_or_ct_pet_performed_outcomes': 'FDG PET/CT outcomes',
 'female_breast_feeding_or_pregnancy_status_indicator': 'female breast feeding or pregnancy stat',
 'ffpe_slide_uuid': 'FFPE slide uuid',
 'first_degree_relative_history_thyrd_glnd_crcnm_dgnss_rltnshp_typ': 'first_degree_relative_history_thyroid_gland_carcinoma_diagnosis_relationship_type',
 'first_diagnosis_age_asth_ecz_hay_fev_mold_dust': '1st Dx age asthma eczema hay fever mold dust',
 'first_diagnosis_age_of_animal_insect_allergy': '1st Dxage of animal insect allergy',
 'first_diagnosis_age_of_food_allergy': '1st Dx age of food allergy',
 'first_nonlymph_node_metastasis_anatomic_site': '1st NLN mets site',
 'first_nonlymph_node_metastasis_anatomic_sites': '1st NLN mets sites',
 'first_pathologic_diagnosis_biospecimen_acquisition_method_type': '1st path Dx biospecimen acquisition method',
 'first_pathologic_diagnosis_biospecimen_acquisition_othr_mthd_txt': 'other acquisition method for 1st path Dx biospecimen',
 'first_presenting_symptom': '1st presenting symptom',
 'first_presenting_symptom_longest_duration': '1st presenting symptom longest duration',
 'first_recurrent_non_nodal_metastatic_anatomic_site_descriptv_txt': 'first_recurrent_non_nodal_metastatic_anatomic_site_descriptive_text',
 'first_recurrent_non_nodal_metastatic_anatomic_site_descrptv_txt': '1st recur non nodal metastatic site',
 'fish_evaluation_performed_ind': 'FISH performed',
 'fluorescence_in_situ_hybrid_cytogenetics_metaphas_ncls_rslt_cnt': 'FISH metaphase nucleus rlt',
 'fluorescence_in_situ_hybrid_cytogenetics_metaphase_ncls_rslt_cnt': 'fluorescence_in_situ_hybrid_cytogenetics_metaphase_nucleus_result_count',
 'fluorescence_in_situ_hybridization_abnormal_result_indicator': 'FISH abnormal rlt',
 'fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng': 'fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range',
 'fluorescence_n_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng': 'FISH Dx chr17 signal range',
 'followup_case_report_form_submission_reason': 'followup case report form submission reason',
 'followup_met_assessment_outcome_success_margin_status': 'followup mets assessment margin status',
 'followup_treatment_success': 'followup Tx success',
 'food_allergy_history': 'food allergy history',
 'food_allergy_types': 'food allergy types',
 'freezing_method': 'freezing method',
 'frequency_of_alcohol_consumption': 'frequency of alcohol consumption',
 'gemistocytes_present': 'gemistocytes present',
 'gender': 'gender',
 'gfap_positive': 'GFAP+',
 'gleason_score': 'gleason_score',
 'gleason_score_combined_pattern_value': 'gleason score',
 'gynecologic_figo_staging_system': 'FIGO staging system',
 'gynecologic_tumor_grouping_figo_stage': 'gynecologic tumor FIGO stage',
 'h_pylori_infection': 'H. Pylori infection',
 'hay_fever_history': 'hay fever history',
 'headache_history': 'headache history',
 'height': 'height',
 'hematology_serum_creatinine_laboratory_result_value_in_mg_dl': 'hematology serum creatinine lab value in mg/dl',
 'hemoglobin_result': 'hemoglobin result',
 'hepatocellular_carcinoma_primary_risk_factor_name': 'hepatocellular carcinoma primary risk factor',
 'hepatocellular_carcinoma_risk_factor_specify': 'hepatocellular carcinoma risk factor',
 'her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt': 'HER2 and centromere 17 positive finding',
 'her2_erbb_method_calculation_method_text': 'HER2 ERBB calculation method',
 'her2_erbb_pos_finding_cell_percent_category': 'HER2/ERBB+ cell percentage',
 'her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt': 'HER2 ERBB+ FISH method',
 'her2_immunohistochemistry_level_result': 'HER2 IHC',
 'her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt': 'HER2 and centromere 17 copy number analy input total number count',
 'her2_neu_breast_carcinoma_copy_analysis_input_total_number': 'HER2 copy analysis input number',
 'her2_neu_chromosone_17_signal_ratio_value': 'HER2/chr17',
 'her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr': 'her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number',
 'her2_neu_metastatic_breast_carcinoma_copy_analysis_npt_ttl_nmbr': 'HER2 neu mets BRCA copy analysis input number',
 'hist_of_non_mibc': 'hist of non mibc (non-muscle-invasive bladder cancer)',
 'histologic_classification': 'histologic classfn',
 'histologic_disease_progression_present_indicator': 'histologic disease prog present',
 'histologic_disease_progression_present_text': 'histologic disease prog txt',
 'histologic_disease_progression_present_type': 'histologic disease prog type',
 'histologic_grading_tier_category': 'histologic_grading_tier_category',
 'histologic_nuclear_grade': 'nuclear grade',
 'histologic_type': 'histologic type',
 'histological_subtype': 'histological_subtype',
 'histological_type': 'histological type',
 'histological_type_other': 'histological_type_other',
 'history_of_chronic_pancreatitis': 'history_of_chronic_pancreatitis',
 'history_of_colon_polyps': 'history of colon polyps',
 'history_of_diabetes': 'history_of_diabetes',
 'history_of_neoadjuvant_treatment': 'history of neoadj Tx',
 'horm_ther': 'horm Tx',
 'hormonal_therapy': 'hormonal Tx',
 'hpv_status_by_ish_testing': 'HPV by FISH',
 'hpv_status_by_p16_testing': 'HPV by p16',
 'hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr': 'HER2 and centromere 17 copy number mets BRCA analysis input total number count',
 'human_papillomavirus_laboratory_procedure_performed_name': 'HPV lab performed name',
 'human_papillomavirus_laboratory_procedure_performed_text': 'HPV lab performed text',
 'human_papillomavirus_other_type_text': 'HPV other type text',
 'human_papillomavirus_type': 'HPV type',
 'hydroxyurea_administration_prior_registration_clinicl_stdy_ndctr': 'hydroxyurea admin prior clinical study',
 'hydroxyurea_agent_administered_day_count': 'hydroxyurea admin day count',
 'hypertension': 'hypertension',
 'hysterectomy_performed_text': 'hysterectomy performed text',
 'hysterectomy_performed_type': 'hysterectomy performed type',
 'i_131_first_administered_dose': 'iodide I-131 first dose',
 'i_131_subsequent_administered_dose': 'iodide I-131 subsequent dose',
 'i_131_total_administered_dose': 'iodide I-131 total dose',
 'i_131_total_administered_preparation_technique': 'iodide I-131 prep technique',
 'icd_10': 'International Classification of Diseases, tenth revision (ICD-10)',
 'icd_o_3_histology': 'ICD-O-3 histology',
 'icd_o_3_site': 'ICD-O-3 site',
 'immuno_therapy': 'immuno Tx',
 'immunohistochemistry_positive_cell_score': 'IHCpositive cell score',
 'immunophenotype_cytochemistry_percent_positive': 'IHC pct positive',
 'immunophenotype_cytochemistry_testing_result': 'IHC result',
 'immunophenotype_cytochemistry_testing_results': 'IHC results',
 'induction_course_complete': 'induction course complete',
 'informed_consent_verified': 'informed consent verified',
 'inherited_genetic_syndrome_found': 'inherited genetic syndrome found',
 'inherited_genetic_syndrome_result': 'inherited genetic syndrome result',
 'init_pathology_dx_method_other': 'init_pathology_dx_method_other',
 'initial_pathologic_diagnosis_method': 'initial path Dx method',
 'initial_weight': 'initial weight',
 'interferon_90_day_prior_excision_admin_indicator': 'interferon 90 day prior excision admin',
 'intermediate_dimension': 'intmed dimension',
 'karnofsky_performance_score': 'karnofsky performance score',
 'karnofsky_performance_status_score': 'karnofsky performance stat score',
 'keratinizing_squamous_cell_carcinoma_present_indicator': 'keratinizing squamous cell carcinoma present indicator',
 'kras_gene_analysis_performed': 'KRAS analysis performed',
 'kras_mutation_codon': 'KRAS mutation codon',
 'kras_mutation_found': 'KRAS mutation',
 'kras_mutation_result': 'KRAS',
 'lab_proc_her2_neu_immunohistochemistry_receptor_status': 'HER2 IHC',
 'lab_procedure_abnormal_lymphocyte_result_percent_value': 'abnormal lymphocyte pct',
 'lab_procedure_blast_cell_outcome_percentage_value': 'blast cell pct',
 'lab_procedure_bone_marrow_band_cell_result_percent_value': 'bone marrow band cell pct',
 'lab_procedure_bone_marrow_basophil_result_percent_value': 'bone marrow basophil pct',
 'lab_procedure_bone_marrow_blast_cell_outcome_percent_value': 'bone marrow blast cell pct',
 'lab_procedure_bone_marrow_cellularity_outcome_percent_value': 'bone marrow cellularity pct',
 'lab_procedure_bone_marrow_diff_not_reported_reason': 'bone marrow diff not reported reason',
 'lab_procedure_bone_marrow_lab_eosinophil_result_percent_value': 'bone marrow eosinophil pct',
 'lab_procedure_bone_marrow_lymphocyte_outcome_percent_value': 'bone marrow lymphocyte pct',
 'lab_procedure_bone_marrow_metamyelocyte_result_value': 'bone marrow metamyelocyte result value',
 'lab_procedure_bone_marrow_myelocyte_result_percent_value': 'bone marrow myelocyte pct',
 'lab_procedure_bone_marrow_neutrophil_result_percent_value': 'bone marrow neutrophil pct',
 'lab_procedure_bone_marrow_prolymphocyte_result_percent_value': 'bone marrow prolymphocyte pct',
 'lab_procedure_bone_marrow_promonocyte_count_result_percent_value': 'bone marrow promonocyte pct',
 'lab_procedure_bone_marrow_promyelocyte_result_percent_value': 'bone marrow promyelocyte pct',
 'lab_procedure_hematocrit_outcome_percent_value': 'hematocrit pct',
 'lab_procedure_hemoglobin_result_specified_value': 'hemoglobin',
 'lab_procedure_her2_neu_in_situ_hybrid_outcome_type': 'her2 neu FISH outcome',
 'lab_procedure_leukocyte_result_unspecified_value': 'leukocyte',
 'lab_procedure_monocyte_result_percent_value': 'monocyte pct',
 'lab_procedure_platelet_result_specified_value': 'platelet',
 'laboratory_prcoedure_platelet_result_lower_limit_of_normal_value': 'platelet result lower limit of normal value',
 'laboratory_prcoedure_platelet_result_upper_limit_of_normal_value': 'platelet result upper limit of normal value',
 'laboratory_procedure_albumin_result_lower_limit_of_normal_value': 'albumin result lower limit of normal value',
 'laboratory_procedure_albumin_result_specified_value': 'albumin result specified value',
 'laboratory_procedure_albumin_result_upper_limit_of_normal_value': 'albumin result upper limit of normal value',
 'laboratory_procedure_alpha_fetoprotein_outcome_lwr_lmt_f_nrml_vl': 'alpha fetoprotein outcome lower limit of normal value',
 'laboratory_procedure_alpha_fetoprotein_outcome_ppr_lmt_f_nrml_vl': 'alpha fetoprotein outcome upper limit of normal value',
 'laboratory_procedure_alpha_fetoprotein_outcome_value': 'alpha fetoprotein value',
 'laboratory_procedure_creatinine_result_lower_limit_of_normal_val': 'creatinine lower limit of normal val',
 'laboratory_procedure_creatinine_result_upper_limit_of_normal_val': 'creatinine upper limit of normal val',
 'laboratory_procedure_interntnl_nrmlztn_rt_rslt_lwr_lmt_f_nrml_vl': 'laboratory_procedure_international_normalization_ratio_result_lower_limit_of_normal_value',
 'laboratory_procedure_interntnl_nrmlztn_rt_rslt_ppr_lmt_f_nrml_vl': 'laboratory_procedure_international_normalization_ratio_result_upper_limit_of_normal_value',
 'laboratory_procedure_intrntnl_nrmlztn_rt_rslt_lwr_lmt_f_nrml_vl': 'international normalization ratio result lower limit of normal value',
 'laboratory_procedure_intrntnl_nrmlztn_rt_rslt_ppr_lmt_f_nrml_vl': 'international normalization ratio result upper limit of normal value',
 'laboratory_procedure_platelet_result_specified_value': 'platelet result specified value',
 'laboratory_procedure_prothrombin_time_result_value': 'prothrombin time result value',
 'laboratory_procedure_total_bilirbn_rslt_spcfd_lwr_lmt_f_nrml_vl': 'total bilirubin result specified lower limit of normal value',
 'laboratory_procedure_total_bilirbn_rslt_spcfd_ppr_lmt_f_nrml_vl': 'total bilirubin result specified upper limit of normal value',
 'laboratory_procedure_total_bilirubin_result_upper_limit_norml_vl': 'total bilirubin result upper limit of normal value',
 'laboratory_procedure_total_bilirubn_rslt_spcfd_lwr_lmt_f_nrml_vl': 'laboratory_procedure_total_bilirubin_result_specified_lower_limit_of_normal_value',
 'laboratory_procedure_total_bilirubn_rslt_spcfd_ppr_lmt_f_nrml_vl': 'laboratory_procedure_total_bilirubin_result_specified_upper_limit_of_normal_value',
 'laboratory_procedure_tumor_marker_squamos_cll_crcnm_ntgn_rslt_vl': 'squamous cell carcinoma antigen value',
 'lactate_dehydrogenase_result': 'lactate dehydrogenase result',
 'laterality': 'laterality',
 'ldh1_mutation_found': 'IDH1 mutation found',
 'ldh1_mutation_test_method': 'IDH1 mutation test method',
 'ldh1_mutation_tested': 'IDH1 mutation tested',
 'leiomyosarcoma_histologic_subtype': 'leiomyosarcoma_histologic_subtype',
 'leiomyosarcoma_major_vessel_involvement': 'leiomyosarcoma_major_vessel_involvement',
 'leptomeningeal_involement': 'leptomeningeal involement',
 'leukemia_french_american_british_morphology_code': 'leukemia french american british morphology code',
 'leukemia_specimen_cell_source_type': 'leukemia specimen cell source type',
 'liver_fibrosis_ishak_score_category': 'liver fibrosis ishak score category',
 'liver_graft_together_new_neoplasm_performed_indicator': 'liver graft new neoplasm performed',
 'local_disease_recurrence': 'local_disease_recurrence',
 'location_in_lung_parenchyma': 'location in lung parenchyma',
 'longest_dimension': 'longest dimension',
 'loss_expression_of_mismatch_repair_proteins_by_ihc': 'loss expression of mismatch repair proteins by IHC',
 'loss_expression_of_mismatch_repair_proteins_by_ihc_result': 'loss expression of mismatch repair proteins by IHC result',
 'loss_expression_of_mismatch_repair_proteins_by_ihc_results': 'loss expression of mismatch repair proteins by IHC results',
 'lost_follow_up': 'lost follow up',
 'lymph_node_examined_count': 'Lymph node count',
 'lymph_node_location_positive_pathology_name': 'LN location positive pathology name',
 'lymph_node_location_positive_pathology_text': 'LN location positive pathology text',
 'lymphatic_invasion': 'lymphatic invasion',
 'lymphatic_invasion_present': 'lymphatic invasion present',
 'lymphnode_dissection_method_left': 'lymphnode dissection method left',
 'lymphnode_dissection_method_right': 'lymphnode dissection method right',
 'lymphnode_neck_dissection': 'lymphnode neck dissection',
 'lymphnode_pathologic_spread': 'lymphnode pathologic spread',
 'lymphnodes_examined': 'lymphnodes examined',
 'lymphnodes_examined_prior_presentation': 'lymphnodes examined prior presentation',
 'lymphovascular_invasion_indicator': 'lymphovascular invasion indicator',
 'lymphovascular_invasion_present': 'lymphovascular invasion present',
 'maint_therapy_course_complete': 'maint therapy course complete',
 'malignant_neoplasm_metastatic_involvement_site': 'malignant neoplasm metastatic involvement site',
 'malignant_neoplasm_mitotic_count_rate': 'malignant neoplasm mitotic count rate',
 'margin_status': 'margin status',
 'margins_involved': 'margins involved',
 'maximum_tumor_dimension': 'maximum_tumor_dimension',
 'melanoma_clark_level_value': 'melanoma clark level',
 'melanoma_origin_skin_anatomic_site': 'melanoma origin skin site',
 'melanoma_primary_anatomic_site': 'melanoma primary site',
 'melanoma_ulceration_indicator': 'melanoma ulceration ind',
 'menopause_status': 'menopause status',
 'mental_status_changes': 'mental status changes',
 'metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt': 'mets-brca PR+ other measure',
 'metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts': 'mets-brca HER2 by ihc',
 'metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt': 'metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result',
 'metastatic_breast_carcinoma_erbb2_immunohistochemistry_lvl_rslt': 'mets-brca ERBB2 by ihc',
 'metastatic_breast_carcinoma_estrogen_receptor_detectin_mthd_txt': 'mets-brca ER detection method',
 'metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt': 'metastatic_breast_carcinoma_estrogen_receptor_detection_method_text',
 'metastatic_breast_carcinoma_estrogen_receptor_status': 'mets-brca ER',
 'metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry': 'metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category',
 'metastatic_breast_carcinoma_estrogen_recptr_lvl_cll_prcnt_ctgry': 'mets-brca ER cell pct',
 'metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt': 'mets-brca HER2 ERBB calculation method',
 'metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry': 'metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category',
 'metastatic_breast_carcinoma_her2_erbb_pos_fndng_cll_prcnt_ctgry': 'mets-brca HER2 ERBB+ cell pct',
 'metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl': 'metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value',
 'metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rt_vl': 'mets-brca HER2 neu chr17 signal ratio value',
 'metastatic_breast_carcinoma_immnhstchmstry_r_pstv_fndng_scl_typ': 'mets-brca ihc ER positive finding scale type',
 'metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ': 'metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type',
 'metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr': 'mets-brca ihc ER positive cell score',
 'metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr': 'mets-brca ihc PR positive cell score',
 'metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ': 'mets-brca FISH HER2 neu',
 'metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt': 'metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text',
 'metastatic_breast_carcinoma_pos_finding_other_scale_measrmnt_txt': 'mets-brca pos other scale measurement',
 'metastatic_breast_carcinoma_pos_findng_hr2_rbb2_thr_msr_scl_txt': 'mets-brca pos finding HER2 ERBB2 other measure scale text',
 'metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry': 'metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category',
 'metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt': 'metastatic_breast_carcinoma_progesterone_receptor_detection_method_text',
 'metastatic_breast_carcinoma_progesterone_receptor_status': 'mets-brca PR',
 'metastatic_breast_carcinoma_progesterone_receptr_dtctn_mthd_txt': 'mets-brca PR detection method',
 'metastatic_breast_carcinoma_progestrn_rcptr_lvl_cll_prcnt_ctgry': 'mets-brca PR cell pct',
 'metastatic_neoplasm_confirmed': 'metastatic_neoplasm_confirmed',
 'metastatic_site_at_diagnosis': 'metastatic_site_at_diagnosis',
 'metastatic_site_at_diagnosis_other': 'metastatic_site_at_diagnosis_other',
 'method_initial_diagnosis': 'method initial Dx',
 'method_of_curative_tx': 'method_of_curative_tx',
 'method_of_sample_procurement': 'method of sample procurement',
 'mib1_positive': 'MIB1 positive',
 'mibc_90day_post_resection_bcg': 'mibc_90day_post_resection_bcg',
 'microsatellite_instability': 'microsatellite instability',
 'mitotic_count': 'mitotic_count',
 'mold_or_dust_allergy_history': 'mold or dust allergy history',
 'molecular_analysis_abnormal_result_indicator': 'molecular analysis abnormal result indicator',
 'molecular_analysis_abnormality_testing_percentage_value': 'molecular analysis abnormality testing percentage value',
 'molecular_analysis_abnormality_testing_result': 'molecular analysis abnormality testing result',
 'molecular_analysis_abnormality_testing_results': 'molecular analysis abnormality testing results',
 'molecular_analysis_performed_indicator': 'molecular analysis performed indicator',
 'mononucleotide_and_dinucleotide_marker_panel_analysis_status': 'MSS',
 'mononucleotide_marker_panel_analysis_status': 'mononucleotide marker panel analysis status',
 'month_chemotherapy_end_number': 'month chemotherapy end number',
 'month_chemotherapy_start_number': 'month chemotherapy start number',
 'month_of_collection': 'month of collection',
 'month_of_form_completion': 'month of form completion',
 'month_of_performance_status_follow_up_score_event': 'month of performance status follow up score event',
 'month_of_sample_procurement': 'month of sample procurement',
 'motor_movement_changes': 'motor movement changes',
 'mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn': 'mets brca FISH Dx proc centromere 17 signal',
 'mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn_': 'mets brca HER2/ERBB2+ FISH calculation method',
 'mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ': 'mets brca IHC PR+ finding scale',
 'neoplasm_anatomic_subdivision': 'neoplasm anatomic subdivision',
 'neoplasm_depth': 'neoplasm depth',
 'neoplasm_disease_lymph_node_stage_american_jont_cmmtt_n_cncr_cd': 'disease lymph node stage AJCC code',
 'neoplasm_disease_stage_american_joint_committee_on_cancer_code': 'disease stage AJCC code',
 'neoplasm_histologic_grade': 'grade',
 'neoplasm_histologic_type_name': 'histologic type',
 'neoplasm_length': 'neoplasm length',
 'neoplasm_width': 'neoplasm width',
 'new_neoplasm_confirmed_diagnosis_method_name': 'new neoplasm Dx method',
 'new_neoplasm_event_occurrence_anatomic_site': 'new neoplasm occur site',
 'new_neoplasm_event_post_initial_therapy_diagnosis_method_text': 'new neoplasm post initial Tx Dx method',
 'new_neoplasm_event_post_initial_therapy_diagnosis_method_type': 'new neoplasm post initial Tx Dx method type',
 'new_neoplasm_event_type': 'new neoplasm type',
 'new_neoplasm_occurrence_anatomic_site_text': 'new neoplasm occur site text',
 'new_non_melanoma_event_histologic_type_text': 'new non melanoma histologic type',
 'new_primary_melanoma_anatomic_site': 'new primary melanoma site',
 'new_primary_melanoma_anatomic_site_other_text': 'new primary melanoma site other text',
 'new_tumor_additional_rad_tx': 'new tumor addtl Rad Tx',
 'new_tumor_additional_rx_tx': 'new tumor addtl Rx Tx',
 'new_tumor_dx_prior_submitted_specimen_dx': 'new tumor Dx prior specimen Dx',
 'new_tumor_event_additional_surgery_procedure': 'new tumor event addtl surgery',
 'new_tumor_event_after_initial_treatment': 'new tumor event after initial treatment',
 'new_tumor_metastasis_anatomic_site': 'new tumor metastasis site',
 'new_tumor_metastasis_anatomic_site_other_text': 'new tumor metastasis site other text',
 'non_mibc_tx': 'non_mibc_tx',
 'non_nodal_tumor_deposits': 'non nodal tumor deposits',
 'number_of_abnormal_loci': 'number of abnormal loci',
 'number_of_first_degree_relatives_with_cancer_diagnosis': 'num of 1st-D relatives with cancer',
 'number_of_loci_tested': 'num of loci tested',
 'number_of_lymphnodes_examined': 'num lymphnodes examined',
 'number_of_lymphnodes_positive': 'num lymphnodes positive',
 'number_of_lymphnodes_positive_by_he': 'num lymphnodes positive by he',
 'number_of_lymphnodes_positive_by_ihc': 'num lymphnodes positive by ihc',
 'number_of_relatives_with_stomach_cancer': 'num relatives with stomach cancer',
 'number_of_successful_pregnancies_which_resultd_n_t_lst_1_lv_brth': 'num successful pregnancies',
 'number_pack_years_smoked': 'number pack years smoked',
 'number_regional_lymphnodes_exam': 'num regional lymphnodes exam',
 'number_regional_lymphnodes_pos': 'num regional lymphnodes pos',
 'occupation_primary_job': 'occupation primary job',
 'oct_embedded': 'oct embedded',
 'oligodendroglial_component': 'oligodendroglial component',
 'oligonucleotide_primer_pair_laboratory_procedure_performed_name': 'oligonucleotide primer pair laboratory procedure performed name',
 'oligonucleotide_primer_pair_laboratory_procedure_performed_text': 'oligonucleotide primer pair laboratory procedure performed text',
 'other_chemotherapy_agent_administration_specify': 'other chemotherapy agent administration specify',
 'other_contiguous_organ_resection_site': 'other_contiguous_organ_resection_site',
 'other_histologic_subtype': 'other histologic subtype',
 'other_metastatic_involvement_anatomic_site': 'other metastatic involvement anatomic site',
 'other_method_of_sample_procurement': 'other method of sample procurement',
 'other_primary_anatomic_site': 'other primary site',
 'overall_gleason_score': 'overall gleason score',
 'p53_gene_analysis': 'TP53 gene analysis',
 'pathologic_M': 'pathologic_M',
 'pathologic_N': 'pathologic_N',
 'pathologic_T': 'pathologic_T',
 'pathologic_spread_pn': 'path spread pn',
 'pathologic_spread_pt2': 'path spread pt2',
 'pathologic_spread_pt2_specify': 'path spread pt2 specify',
 'pathologic_spread_pt3': 'path spread pt3',
 'pathologic_spread_pt3_specify': 'path spread pt3 specify',
 'pathologic_spread_pt4': 'path spread pt4',
 'pathologic_stage': 'pathologic_stage',
 'pathologic_tumor_burden': 'pathologic_tumor_burden',
 'pathologic_tumor_depth': 'pathologic_tumor_depth',
 'pathologic_tumor_length': 'pathologic_tumor_length',
 'pathologic_tumor_width': 'pathologic_tumor_width',
 'pathology_report_uuid': 'pathology report uuid',
 'patient_death_reason': 'patient death reason',
 'patient_history_immune_system_and_related_disorders_name': 'patient history immune system and related disorders name',
 'patient_history_immune_system_and_related_disorders_text': 'patient history immune system and related disorders text',
 'patient_id': 'patient id',
 'patient_pregnancy_spontaneous_abortion_count': 'patient pregnancy spontaneous abortion count',
 'patient_pregnancy_therapeutic_abortion_count': 'patient pregnancy therapeutic abortion count',
 'patient_smoking_history_category': 'patient smoking history category',
 'pct_tumor_invasion': 'pct tumor invasion',
 'percent_tumor_sarcomatoid': 'percent_tumor_sarcomatoid',
 'performance_status_assessment_eastern_cooperative_onclgy_grp_scl': 'performance status assessment eastern cooperative oncology group scale',
 'performance_status_assessment_timepoint_category': 'performance status assessment timepoint category',
 'performance_status_assessment_timepoint_category_other_text': 'performance status assessment timepoint category other text',
 'performance_status_scale_timing': 'performance status scale timing',
 'perineural_invasion_present': 'perineural invasion present',
 'peritoneal_wash': 'peritoneal wash',
 'person_cigarette_smoking_history_pack_year_value': 'person cigarette smoking history pack year value',
 'person_concomitant_prostate_carcinoma_occurrence_indicator': 'person concomitant prostate carcinoma occurrence indicator',
 'person_concomitant_prostate_carcinoma_pathologic_t_stage': 'person concomitant prostate carcinoma pathologic t stage',
 'person_history_leukemogenic_agent_other_exposure_text': 'person history leukemogenic agent other exposure text',
 'person_history_nonmedical_leukemia_causing_agent_type': 'person history nonmedical leukemia causing agent type',
 'person_menopause_status': 'person menopause status',
 'person_neoplasm_cancer_status': 'person neoplasm cancer status',
 'person_occupation_description_text': 'person occupation description text',
 'person_occupation_years_number': 'person occupation years number',
 'person_primary_industry_text': 'person primary industry text',
 'pgr_detection_method_text': 'PGR detection method text',
 'platelet_qualitative_result': 'platelet qualitative result',
 'pln_pos_ihc': 'positive lymph nodes (pln) by ihc',
 'pln_pos_light_micro': 'positive lymph nodes (pln) by light microscopy',
 'pos_finding_her2_erbb2_other_measurement_scale_text': 'positive finding HER2 ERBB2 other measurement scale text',
 'pos_finding_lymph_node_hematoxylin_and_eosin_stainng_mcrscpy_cnt': 'pos finding lymph node hematoxylin and eosin staining microscopy count',
 'pos_finding_lymph_node_keratin_immunohistchmstry_stnng_mthd_cnt': 'pos finding lymph node keratin immunohistochemistry staining method count',
 'pos_finding_metastatc_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt': 'pos finding metastatic breast carcinoma estrogen receptor other measuremenet scale text',
 'pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt': 'pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text',
 'pos_finding_progesterone_receptor_other_measurement_scale_text': 'pos finding progesterone receptor other measurement scale text',
 'positive_finding_estrogen_receptor_other_measurement_scale_text': 'positive finding estrogen receptor other measurement scale text',
 'positive_finding_lymph_node_hematoxylin_nd_sn_stnng_mcrscpy_cnt': 'positive finding lymph node hematoxylin and eosin staining microscopy count',
 'positive_finding_lymph_node_keratin_mmnhstchmstry_stnng_mthd_cnt': 'positive finding lymph node keratin immunohistochemistry staining method count',
 'post_bronchodilator_fev1_fvc_percent': 'post bronchodilator FEV1/FVC pct',
 'post_bronchodilator_fev1_percent': 'post bronchodilator FEV1 pct',
 'post_surgical_procedure_assessment_thyroid_gland_carcinoma_stats': 'post_surgical_procedure_assessment_thyroid_gland_carcinoma_status',
 'post_surgical_procedure_assessment_thyroid_gland_carcinoma_stts': 'post surgery THCA stats',
 'postoperative_rx_tx': 'postop Rx Tx',
 'pre_bronchodilator_fev1_fvc_percent': 'pre bronchodilator FEV1/FVC pct',
 'pre_bronchodilator_fev1_percent': 'pre bronchodilator FEV1 pct',
 'pregnancies': 'pregnancies',
 'pregnancy_stillbirth_count': 'pregnancy stillbirth count',
 'pregnant_at_diagnosis': 'pregnant_at_diagnosis',
 'preoperative_antiseizure_meds': 'preoperative antiseizure meds',
 'preoperative_corticosteroids': 'preoperative corticosteroids',
 'preoperative_pretreatment_cea_level': 'preoperative pretreatment cea level',
 'presence_of_pathological_nodal_extracapsular_spread': 'presence of pathological nodal extracapsular spread',
 'presence_of_sarcomatoid_features': 'presence_of_sarcomatoid_features',
 'pretreatment_history': 'pre treatment',
 'primary_anatomic_site_count': 'primary site count',
 'primary_gleason_grade': 'primary gleason grade',
 'primary_lymph_node_presentation_assessment': 'primary lymph node presentation',
 'primary_melanoma_at_diagnosis_count': 'primary melanoma at Dx count',
 'primary_neoplasm_melanoma_dx': 'primary melanoma Dx',
 'primary_or_metastatic_status': 'primary or metastatic status',
 'primary_ormetastatic_status': 'primary ormetastatic status',
 'primary_other_site_of_disease_name': 'primary other site of disease name',
 'primary_pattern': 'primary_pattern',
 'primary_therapy_outcome_success': 'primary therapy outcome success',
 'primary_therapy_outcome_success_type': 'primary therapy outcome success type',
 'primary_tumor_lower_uterus_segment': 'primary_tumor_lower_uterus_segment',
 'primary_tumor_multiple_present_ind': 'primary tumor mul present',
 'primary_tumor_pathologic_spread': 'primary tumor pathologic spread',
 'prior_diagnosis': 'prior diagnosis',
 'prior_dx': 'prior Dx',
 'prior_glioma': 'prior glioma',
 'prior_hematologic_disorder_diagnosis_indicator': 'prior hematologic disorder diagnosis indicator',
 'prior_radiation_therapy': 'prior rad Tx',
 'prior_systemic_therapy_type': 'prior system Tx',
 'prior_tamoxifen_administered_usage_category': 'prior tamoxifen administered usage category',
 'progesterone_receptor_level_cell_percent_category': 'progesterone receptor level cell percent category',
 'progression_determined_by': 'progression determined by',
 'progression_determined_by_notes': 'progression determined by notes',
 'prosp_tissue_coll': 'prospect tissue collection',
 'psa_result_most_recent': 'PSA result most recent',
 'psa_value': 'psa_value',
 'pulmonary_function_test_performed': 'pulmonary function test performed',
 'rad_tx_primary_neoplasm_admin': 'rad Tx primary neoplasm',
 'radiation_supplemental': 'radiation supplemental',
 'radiation_therapy': 'radiation therapy',
 'radiation_therapy_administered_dose_text': 'rad Tx dose',
 'radiation_therapy_administered_preparation_technique_text': 'rad Rx prep technique',
 'radiation_therapy_not_administered_reason': 'radiation therapy not administered reason',
 'radiation_therapy_not_administered_specify': 'radiation therapy not administered specify',
 'radiation_type_notes': 'radiation type notes',
 'radiologic_tumor_burden': 'radiologic_tumor_burden',
 'radiologic_tumor_depth': 'radiologic_tumor_depth',
 'radiologic_tumor_length': 'radiologic_tumor_length',
 'radiologic_tumor_width': 'radiologic_tumor_width',
 'radiosensitizing_agent_administered_indicator': 'radiosensitizing agent administered',
 'recurrence_second_surgery_neoplasm_surgical_procedure_name': 'recurrence second surgery neoplasm surgical procedure name',
 'recurrence_second_surgery_neoplasm_surgical_procedure_name_other': 'recurrence second surgery neoplasm surgical procedure name other',
 'reflux_history': 'reflux history',
 'relative_cancer_type': 'relative_cancer_type',
 'relative_family_cancer_history_ind_3': 'family cancer history ind 3',
 'residual_disease_post_new_tumor_event_margin_status': 'residual disease post new tumor event margin status',
 'residual_tumor': 'residual tumor',
 'retro_tissue_coll': 'retrospect tissue collection',
 'rt_administered_type': 'radiation administered type',
 'rt_pelvis_administered_total_dose': 'radiation pelvis administered total dose',
 'sample_type': 'sample type',
 'sample_type_id': 'sample type id',
 'secondary_gleason_grade': 'secondary gleason grade',
 'secondary_pattern': 'secondary_pattern',
 'seizure_history': 'seizure history',
 'sensory_changes': 'sensory changes',
 'serum_calcium_result': 'serum calcium result',
 'shortest_dimension': 'shortest dimension',
 'site_of_additional_surgery_new_tumor_event_mets': 'site of addtl surgery new mets',
 'site_of_tumor_first_recurrence': 'site of tumor first recurrence',
 'smokeless_tobacco_use_age_at_quit': 'smokeless_tobacco_use_age_at_quit',
 'smokeless_tobacco_use_age_at_start': 'smokeless_tobacco_use_age_at_start',
 'smokeless_tobacco_use_at_diag': 'smokeless_tobacco_use_at_diag',
 'smokeless_tobacco_use_per_day': 'smokeless_tobacco_use_per_day',
 'smokeless_tobacco_use_regularly': 'smokeless_tobacco_use_regularly',
 'source_of_patient_death_reason': 'source of patient death reason',
 'specific_tumor_total_necrosis_percent': 'specific_tumor_total_necrosis_percent',
 'specimen_collection_method_name': 'specimen collection method name',
 'specimen_histologic_type_type_histologictype': 'specimen histologic type type histologictype',
 'standardized_uptake_value_cervix_uteri_assessment_measurement': 'standardized uptake value cervix uteri assessment measurement',
 'state_province_country_of_procurement': 'state province country of procurement',
 'steroid_therapy_administered': 'steroid therapy administered',
 'stomach_neoplasm_anatomic_subsite': 'stomach neoplasm anatomic subsite',
 'stopped_smoking_year': 'stopped smoking year',
 'subsequent_primary_melanoma_during_followup': 'subsequent primary melanoma during followup',
 'supratentorial_localization': 'supratentorial localization',
 'surgery_performed_type': 'surgery_performed_type',
 'surgery_performed_type_other': 'surgery_performed_type_other',
 'surgical_approach': 'surgical approach',
 'surgical_margin_resection_status': 'surgical margin resection status',
 'surgical_procedure_name_other_specify_text': 'surgical procedure name other specify text',
 'surgical_procedure_purpose_other_text': 'surgical procedure purpose other text',
 'synchronous_colon_cancer_present': 'synchronous colon cancer present',
 'system_version': 'system_version',
 'targeted_molecular_therapy': 'targeted molecular therapy',
 'tcgaBarCode': 'tcgaBarCode',
 'tertiary_gleason_pattern': 'tertiary gleason pattern',
 'tertiary_pattern': 'tertiary_pattern',
 'therapeutic_ionizing_head_radiation': 'therapeutic ionizing head radiation',
 'therapeutic_procedure_new_neoplasm_required_additional_thrpy_typ': 'therapeutic_procedure_new_neoplasm_required_additional_therapy_type',
 'therapeutic_procedure_new_neoplasm_required_additionl_thrpy_typ': 'Tx proc new neoplasm addtl Tx',
 'thyroid_gland_carcinoma_involvement_regional_lymph_node_type': 'THCA regional LN type',
 'thyroid_gland_carcinoma_regional_lymph_nod_nvlvmnt_ntmc_sts_txt': 'THCA regional LN site',
 'thyroid_gland_carcinoma_regional_lymph_node_nvlvmnt_ntmc_sts_txt': 'thyroid_gland_carcinoma_regional_lymph_node_involvement_anatomic_sites_text',
 'time_between_clamping_and_freezing': 'time between clamping and freezing',
 'time_between_excision_and_freezing': 'time between excision and freezing',
 'tissue_prospective_collection_indicator': 'tissue prospective collection indicator',
 'tissue_retrospective_collection_indicator': 'tissue retrospective collection indicator',
 'tissue_source_site': 'tissue source site',
 'tnm_pathology_lymphnode_status': 'N (TNM)',
 'tnm_pathology_metastatic_status': 'M (TNM)',
 'tnm_pathology_stage_grouping': 'stage (TNM)',
 'tnm_pathology_tumor_status': 'T (TNM)',
 'tobacco_smoking_history': 'tobacco_smoking_history',
 'tobacco_smoking_history_indicator': 'smoking history',
 'total_aor-lnp': 'total aor lymph node positive',
 'total_aor_lnp': 'total_aor-lnp',
 'total_aor_lnr': 'total aor lymph node ratio',
 'total_dose_units': 'total dose units',
 'total_number_of_pregnancies': 'total number of pregnancies',
 'total_pelv_lnp': 'total pelv lymph node positive',
 'total_pelv_lnr': 'total pelv lymph node ratio',
 'tumor_anatomic_site': 'tumor_anatomic_site',
 'tumor_depth': 'tumor_depth',
 'tumor_disease_anatomic_site': 'tumor site',
 'tumor_grade': 'tumor grade',
 'tumor_histologic_subtype': 'tumor histologic subtype',
 'tumor_histologic_subtype_type': 'tumor histologic subtype',
 'tumor_level': 'tumor level',
 'tumor_location': 'tumor location',
 'tumor_lymphovascular_invasion_ind': 'tumor lymphovascular invasion',
 'tumor_multifocal': 'tumor_multifocal',
 'tumor_necrosis_percent': 'tumor necrosis pct',
 'tumor_nuclei_percent': 'tumor nuclei pct',
 'tumor_other_histologic_subtype_descriptive_text': 'tumor other histologic subtype descriptive text',
 'tumor_pathology': 'tumor pathology',
 'tumor_residual_disease': 'tumor residual disease',
 'tumor_response_cdus_type': 'tumor response CDUS (colour doppler ultrasound) type',
 'tumor_sample_anatomic_location': 'tumor sample anatomic location',
 'tumor_stage': 'tumor stage',
 'tumor_tissue_site': 'tumor tissue site',
 'tumor_tissue_site_other': 'tumor_tissue_site_other',
 'tumor_total_necrosis_percent': 'tumor_total_necrosis_percent',
 'tumor_type': 'tumor type',
 'tumor_weight': 'tumor weight',
 'type_ofprogression_of_disease_ht': 'type of progression',
 'vascular_invasion_present': 'vascular invasion present',
 'vascular_tumor_cell_invasion_type': 'vascular tumor cell invasion type',
 'venous_invasion': 'venous invasion',
 'verification_by_bcr': 'verification by BCR',
 'vial_number': 'vial number',
 'visual_changes': 'visual changes',
 'vital_status': 'vital status',
 'weight': 'weight',
 'well_differentiated_liposarcoma_primary_dx': 'well_differentiated_liposarcoma_primary_dx',
 'white_cell_count_result': 'white cell count result',
 'year_chemotherapy_end_number': 'year chemotherapy end number',
 'year_chemotherapy_start_number': 'year chemotherapy start number',
 'year_of_collection': 'year of collection',
 'year_of_form_completion': 'year of form completion',
 'year_of_initial_pathologic_diagnosis': 'year of initial pathologic diagnosis',
 'year_of_performance_status_follow_up_score': 'year of performance status follow up score',
 'year_of_sample_procurement': 'year of sample procurement',
 'year_of_tobacco_smoking_cessation': 'year of tobacco smoking cessation',
 'year_of_tobacco_smoking_onset': 'year of tobacco smoking onset',
 'zone_of_origin': 'zone of origin',
 'percent_lymphocyte_infiltration_BOTTOM':'percent_lymphocyte_infiltration BOTTOM of slide',
 'percent_lymphocyte_infiltration_TOP':'percent_lymphocyte_infiltration TOP of slide',
 'percent_monocyte_infiltration_BOTTOM':'percent_monocyte_infiltration BOTTOM of slide',
 'percent_monocyte_infiltration_TOP':'percent_monocyte_infiltration TOP of slide',
 'percent_necrosis_BOTTOM':'percent_necrosis BOTTOM of slide',
 'percent_necrosis_TOP':'percent_necrosis TOP of slide',
 'percent_neutrophil_infiltration_BOTTOM':'percent_neutrophil_infiltration BOTTOM of slide',
 'percent_neutrophil_infiltration_TOP':'percent_neutrophil_infiltration TOP of slide',
 'percent_normal_cells_BOTTOM':'percent_normal_cells BOTTOM of slide',
 'percent_normal_cells_TOP':'percent_normal_cells TOP of slide',
 'percent_stromal_cells_BOTTOM':'percent_stromal_cells BOTTOM of slide',
 'percent_stromal_cells_TOP':'percent_stromal_cells TOP of slide',
 'percent_tumor_cells_BOTTOM':'percent_tumor_cells BOTTOM of slide',
 'percent_tumor_cells_TOP':'percent_tumor_cells TOP of slide',
 'percent_tumor_nuclei_BOTTOM':'percent_tumor_nuclei BOTTOM of slide',
 'percent_tumor_nuclei_TOP':'percent_tumor_nuclei TOP of slide',
